RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE epsilon4 on Alzheimer's Disease Risk in a Multiracial Sample

J Clin Med 8(8):1236 · 2019 · PMID 31426376

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

2,082편 검색→1,926편 판독→889편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: APOE polymorphisms and Alzheimer disease risk APOE polymorphisms and Alzheimer disease risk

출판 연도

1997: 4편419971998: 31편311999: 28편282000: 35편3520002001: 25편252002: 25편252003: 19편192004: 30편302005: 23편2320052006: 30편302007: 27편272008: 30편302009: 38편382010: 35편3520102011: 34편342012: 43편432013: 35편352014: 36편362015: 37편3720152016: 46편462017: 32편322018: 36편362019: 27편272020: 34편3420202021: 33편332022: 21편212023: 14편142024: 22편222025: 33편332026: 26편262026

선별된 889편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01allele · frequency210편

  1. 0.96

    High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population

    Rassas AA, Mrabet Khiari H, Hadj Fredj S et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2012

  2. 0.96

    Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study

    Ganguli M, Chandra V, Kamboh MI et al. · Archives of neurology · 2000

  3. 0.96

    Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans RECODE

    Kim KW, Jhoo JH, Lee KU et al. · Neuroscience letters · 1999

  4. 0.96

    Association between apolipoprotein E gene polymorphism and Alzheimer's disease in Uighur and Han populations

    Zhou X, Miao H, Rausch WD et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2012

  5. 0.96

    A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease

    Kamboh MI, Aston CE, Perez-Tur J et al. · Neuroscience letters · 1999

  6. 0.96

    Association between Alzheimer's Disease and Apolipoprotein E Polymorphisms

    Gozalpour E, Kamali K, Mohammd K et al. · Iranian journal of public health · 2010

  7. 0.95

    Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran

    Raygani AV, Zahrai M, Raygani AV et al. · Neuroscience letters · 2005

  8. 0.95

    Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years

    Breitner JC, Jarvik GP, Plassman BL et al. · Alzheimer disease and associated disorders · 1998

  9. 0.95

    Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study

    Ohara T, Ninomiya T, Kubo M et al. · Journal of the American Geriatrics Society · 2011

  10. 0.95

    Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group

    Siest G, Bertrand P, Qin B et al. · Clinical chemistry and laboratory medicine · 2000

  11. 0.95

    Apolipoprotein E gene variants of Alzheimer's disease and vascular dementia patients in a community population of Nanking

    Chu WZ, Gong L, Xu YQ et al. · Medicinal chemistry (Shariqah (United Arab Emirates)) · 2014

  12. 0.95

    Variation at APOE and STH loci and Alzheimer's disease

    Zuo L, van Dyck CH, Luo X et al. · Behavioral and brain functions : BBF · 2006

  13. 0.95

    Apolipoprotein E polymorphism and Alzheimer's disease

    Yen YC, Liu CK, Lung FW et al. · The Kaohsiung journal of medical sciences · 2001

  14. 0.95

    Analysis of apolipoprotein E genetic variation in patients with Alzheimer disease referred to Imam Reza Clinic, Rasht, Iran, in 2015

    Ghayeghran AR, Akbarshahi M, Salehi Z et al. · Iranian journal of neurology · 2017

  15. 0.95

    APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease

    Frikke-Schmidt R, Nordestgaard BG, Thudium D et al. · Neurology · 2001

  16. 0.95

    Apolipoprotein E polymorphism in Alzheimer's disease: a comparative study of two research populations from Spain and the United States

    Lopez OL, Lopez-Pousa S, Kamboh MI et al. · European neurology · 1998

  17. 0.95

    Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease

    Kowalska A, Florczak J, Pruchnik-Wolinska D et al. · Archivum immunologiae et therapiae experimentalis · 1998

  18. 0.94

    Association of Apolipoprotein E (ApoE) Polymorphism with Alzheimer's Disease in Chinese Population

    Zheng L, Duan J, Duan X et al. · Current Alzheimer research · 2016

  19. 0.94

    APOE epsilon4 and late-onset Alzheimer's disease in Syria: A case-control study

    Labbad I, Youssef LA, Rustom M et al. · Journal of Alzheimer's disease : JAD · 2026

  20. 0.94

    Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan

    Nakayama S, Kuzuhara S · Psychiatry and clinical neurosciences · 1999

  21. 0.94

    APOE epsilon4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area

    Fan YY, Cai QL, Gao ZY et al. · Brain research bulletin · 2017

  22. 0.94

    Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia

    Luthra K, Tripathi M, Grover R et al. · Dementia and geriatric cognitive disorders · 2004

  23. 0.94

    Protective effect of the APOE-e3 allele in Alzheimer's disease

    de-Almada BVP, de-Almeida LD, Camporez D et al. · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2012

  24. 0.94

    APOE epsilon4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans

    Yu L, Lutz MW, Wilson RS et al. · PloS one · 2017

  25. 0.94

    Association of APOE polymorphisms and stressful life events with dementia in a Pakistani population

    Chaudhry M, Hasnain S, Snitz BE et al. · Neuroscience letters · 2014

  26. 0.94

    Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study

    Khachaturian AS, Corcoran CD, Mayer LS et al. · Archives of general psychiatry · 2004

  27. 0.93

    The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population

    Li Z, Yang N, Lei X et al. · Journal of clinical laboratory analysis · 2019

  28. 0.93

    Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians

    Souza DRS, de Godoy MR, Hotta J et al. · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2003

  29. 0.93

    Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study

    Zhou L, Li HY, Wang JH et al. · Medicine · 2018

  30. 0.93

    Polymorphism of apolipoproteine E in relation with Alzheimer and vascular dementia

    Gdovinova Z, Habalova V, Novosadova Z · Cellular and molecular neurobiology · 2006

  31. 0.93

    Association of Alzheimer's Disease With APOE and IL-1alpha Gene Polymorphisms

    Yildiz SH, Erdogan MO, Artan S et al. · American journal of Alzheimer's disease and other dementias · 2015

  32. 0.93

    Frequency distribution of apolipoprotein E genotypes in elderly population and relationship with senile dementia

    Huang W, Chen M, Zhang Y et al. · Journal of neurosurgical sciences · 2020

  33. 0.93

    Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population

    Kim HC, Kim DK, Choi IJ et al. · Psychiatry and clinical neurosciences · 2001

  34. 0.92

    Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia

    Wang HK, Fung HC, Hsu WC et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2006

  35. 0.92

    Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer's disease

    Smach MA, Charfeddine B, Lammouchi T et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2010

  36. 0.92

    Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China

    Chen KL, Sun YM, Zhou Y et al. · Psychiatric genetics · 2016

  37. 0.92

    Alzheimer's disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes

    Mustapic M, Popovic Hadzija M, Pavlovic M et al. · Metabolic brain disease · 2012

  38. 0.92

    Protective association of the epsilon2/epsilon3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men

    Kulminski AM, Philipp I, Loika Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021

  39. 0.92

    Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer's Disease: An Observational Case-Control Study

    Bello-Corral L, Seco-Calvo J, Molina Fresno A et al. · Medicina (Kaunas, Lithuania) · 2024

  40. 0.92

    Missing apolipoprotein E epsilon4 allele associated with nonamnestic Alzheimer's disease in a Tunisian population

    Fray S, Achouri-Rassas A, Belal S et al. · Journal of genetics · 2022

  41. 0.92

    Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease

    Cui T, Zhou X, Jin W et al. · Chinese medical journal · 2000

  42. 0.92

    APOE2 and consanguinity: a risky combination for Alzheimer's disease

    Kaur M, Balgir PP · Journal of Alzheimer's disease : JAD · 2005

  43. 0.92

    Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample

    Kwon OD, Khaleeq A, Chan W et al. · Dementia and geriatric cognitive disorders · 2010

  44. 0.92

    Apolipoprotein varepsilon4 Allele and Dental Occlusion Deficiency as Risk Factors for Alzheimer's Disease

    Popovac A, Mladenovic I, Krunic J et al. · Journal of Alzheimer's disease : JAD · 2020

  45. 0.91

    Age at natural menopause, reproductive lifespan and Alzheimer's disease in females: is APOE epsilon4 the missing link?

    Bruno F, Spadafora P, Abondio P et al. · Frontiers in genetics · 2026

  46. 0.91

    Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease

    Shi Z, Yu H, Wu Y et al. · Clinical genetics · 2019

  47. 0.91

    Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan

    Hu CJ, Sung SM, Liu HC et al. · Journal of the neurological sciences · 2000

  48. 0.91

    Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India

    Chandak GR, Sridevi MU, Vas CJ et al. · Human biology · 2002

  49. 0.91

    Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease

    Licastro F, Pedrini S, Govoni M et al. · Neuroscience letters · 1999

  50. 0.91

    TOMM40 and APOC1 variants differentiate the impacts of the APOE epsilon4 allele on Alzheimer's disease risk across sexes, ages, and ancestries

    Kulminski AM, Jain-Washburn E, Philipp I et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  51. 0.91

    Gene-environment interaction in Alzheimer's disease

    Singh NK, Chhillar N, Banerjee BD et al. · American journal of Alzheimer's disease and other dementias · 2012

  52. 0.91

    The Association between Sporadic Alzheimer's Disease and the Human ABCA1 and APOE Gene Polymorphisms in Iranian Population

    Khorram Khorshid HR, Gozalpour E, Kamali K et al. · Iranian Red Crescent medical journal · 2011

  53. 0.91

    Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly

    Warzok RW, Kessler C, Apel G et al. · Alzheimer disease and associated disorders · 1998

  54. 0.91

    Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease

    Wang PN, Liu HC, Liu TY et al. · Dementia and geriatric cognitive disorders · 2005

  55. 0.91

    ApoE epsilon4 and IL-6-174G/C Polymorphism may Lead to Early Onset of Alzheimer's Disease with Atypical Presentation

    Chakraborty S, Joardar A, Roy S et al. · Neurology India · 2021

  56. 0.90

    Regional analysis of APOE polymorphism in Alzheimer's disease in Spain

    Pardo-Perez I, Sanchez-Valdeon L, Garcia-Gallego A et al. · Scientific reports · 2025

  57. 0.90

    Presenilin gene predisposes to late-onset degenerative but not vascular dementia: a comparative study of PS1 and ApoE genes in a North Indian Cohort

    Pandey P, Pradhan S, Mittal B · Dementia and geriatric cognitive disorders · 2007

  58. 0.90

    Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?

    Fernandez LL, Scheibe RM · Arquivos de neuro-psiquiatria · 2005

  59. 0.90

    epsilon3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus

    Tang Y, Li YM, Zhang M et al. · Gene · 2019

  60. 0.90

    The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily

    Bosco P, Caraci F, Copani A et al. · Neuroscience letters · 2007

  61. 0.90

    Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer's Disease in the Lithuanian Population

    Psemeneckiene G, Petrikonis K, Rastenyte AD · Medicina (Kaunas, Lithuania) · 2019

  62. 0.90

    Interleukin-6 gene (-174 C/G ) and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population

    Klimkowicz-Mrowiec A, Wolkow P, Spisak K et al. · Neurologia i neurochirurgia polska · 2010

  63. 0.90

    Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease

    Scacchi R, Gambina G, Ruggeri M et al. · Neuroscience letters · 1999

  64. 0.90

    Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE

    Yamanaka H, Kamimura K, Tanahashi H et al. · Neurobiology of aging · 1998

  65. 0.90

    Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia--an epidemiological study using the polymerase chain reaction (PCR) method

    Nishiyama M, Kato Y, Hashimoto M et al. · Journal of epidemiology · 2000

  66. 0.90

    Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease

    Bruno E, Quattrocchi G, Nicoletti A et al. · Neuroscience letters · 2010

  67. 0.90

    Apolipoprotein E Pittsburgh variant is not associated with the risk of late-onset Alzheimer's disease in a Spanish population

    Baron M, Jimenez-Escrig A, Orensanz L et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2003

  68. 0.90

    Genetic analysis of vascular factors in Alzheimer's disease

    Wakutani Y, Kowa H, Kusumi M et al. · Annals of the New York Academy of Sciences · 2002

  69. 0.89

    Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases

    Lamb H, Christie J, Singleton AB et al. · Neurology · 1998

  70. 0.89

    Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease

    Huang Y, Zheng L, Halliday G et al. · Current Alzheimer research · 2011

  71. 0.89

    Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism

    Kamruecha W, Chansirikarnjana S, Nimkulrat E et al. · The Southeast Asian journal of tropical medicine and public health · 2006

  72. 0.88

    Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population

    Sheu KF, Brown AM, Haroutunian V et al. · Annals of neurology · 1999

  73. 0.88

    Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population

    Klimkowicz-Mrowiec A, Marona M, Wolkow P et al. · Dementia and geriatric cognitive disorders · 2009

  74. 0.88

    Correlation between Apolipoprotein-E polymorphism and Alzheimer's disease pathology

    Cruz-Sanchez FF, Durany N, Thome J et al. · Journal of Alzheimer's disease : JAD · 2000

  75. 0.88

    Apolipoprotein E gene in physiological and pathological aging

    Ferri E, Gussago C, Casati M et al. · Mechanisms of ageing and development · 2019

  76. 0.88

    Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women

    Mattila KM, Axelman K, Rinne JO et al. · Neuroscience letters · 2000

  77. 0.88

    Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology

    Mattila KM, Rinne JO, Roytta M et al. · Journal of medical genetics · 2000

  78. 0.88

    The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E

    Helisalmi S, Valve R, Karvonen MK et al. · Neuroscience letters · 2000

  79. 0.88

    Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer's disease and vascular dementia

    Alam R, Tripathi M, Mansoori N et al. · American journal of Alzheimer's disease and other dementias · 2014

  80. 0.87

    Choline acetyltransferase 2384G>a polymorphism and the risk of Alzheimer disease RECODE

    Lee JJ, Jo SA, Park JH et al. · Alzheimer disease and associated disorders · 2012

  81. 0.87

    Sociodemographic characteristics, clinical factors, and genetic polymorphisms associated with Alzheimer's disease

    Bicalho MAC, Pimenta FA, Bastos-Rodrigues L et al. · International journal of geriatric psychiatry · 2013

  82. 0.87

    ApoE polymorphism in Polish patients with Alzheimer's disease

    Lalowski MM, Czyzewski K, Pfeffer A et al. · Acta neurobiologiae experimentalis · 1998

  83. 0.87

    Phenome-wide association of APOE alleles in the All of Us Research Program

    Khajouei E, Ghisays V, Piras IS et al. · EBioMedicine · 2025

  84. 0.86

    Apolipoprotein E polymorphism in elderly east Africans

    Sayi JG, Patel NB, Premkumar DR et al. · East African medical journal · 1997

  85. 0.86

    ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia

    Chapman J, Wang N, Treves TA et al. · Stroke · 1998

  86. 0.86

    Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms

    Berr C, Lambert JC, Sazdovitch V et al. · Neurobiology of aging · 2001

  87. 0.86

    ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias

    Rogalski EJ, Rademaker A, Harrison TM et al. · Alzheimer disease and associated disorders · 2011

  88. 0.86

    Apolipoprotein E genotypes and longevity across dementia disorders

    Skillback T, Lautner R, Mattsson N et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018

  89. 0.86

    Apo E and Apo CI loci are associated with dementia in younger but not older late-onset cases

    Tysoe C, Galinsky D, Robinson D et al. · Dementia and geriatric cognitive disorders · 1998

  90. 0.86

    Potential genetic markers of sporadic Alzheimer's dementia

    Retz W, Thome J, Durany N et al. · Psychiatric genetics · 2001

  91. 0.85

    Frequency of Cardiovascular Genetic Risk Factors in a Calabrian Population and Their Effects on Dementia

    Maletta R, Smirne N, Bernardi L et al. · Journal of Alzheimer's disease : JAD · 2018

  92. 0.85

    Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease

    Carrieri G, Bonafe M, De Luca M et al. · Human genetics · 2001

  93. 0.85

    Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia

    Orsitto G, Seripa D, Panza F et al. · Dementia and geriatric cognitive disorders · 2007

  94. 0.84

    Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease

    Paz-y-Mino C, Carrera C, Lopez-Cortes A et al. · The American journal of the medical sciences · 2010

  95. 0.84

    Interleukin-1beta Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease

    Yin Y, Liu Y, Pan X et al. · PloS one · 2016

  96. 0.84

    Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases

    Calero O, Bullido MJ, Clarimon J et al. · PloS one · 2011

  97. 0.84

    Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease

    Mooser V, Helbecque N, Miklossy J et al. · Annals of internal medicine · 2000

  98. 0.83

    Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians

    Zambenedetti P, De Bellis G, Biunno I et al. · Journal of Alzheimer's disease : JAD · 2003

  99. 0.83

    Behavioural effects of the ACE insertion/deletion polymorphism in Alzheimer's disease depend upon stratification according to APOE-ϵ4 carrier status

    Oliveira FFd, de Almeida SS, Smith MC et al. · Cognitive neuropsychiatry · 2021

  100. 0.83

    Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism

    Lehtovirta M, Kuikka J, Helisalmi S et al. · Journal of neurology, neurosurgery, and psychiatry · 1998

  101. 0.83

    Roles of the tau gene short tandem repeats in late-onset Alzheimer's disease

    Dong S, Chu L, Liu F et al. · The International journal of neuroscience · 2012

  102. 0.83

    Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease

    Feher A, Juhasz A, Rimanoczy A et al. · Alzheimer disease and associated disorders · 2009

  103. 0.83

    Mediation of the APOE associations with Alzheimer's and coronary heart diseases through body mass index and lipids

    Loika Y, Feng F, Loiko E et al. · GeroScience · 2022

  104. 0.82

    Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

    Solfrizzi V, Panza F, D'Introno A et al. · Journal of neurology, neurosurgery, and psychiatry · 2002

  105. 0.82

    Regional quantitative analysis of NFT in brains of non-demented elderly persons: comparisons with findings in brains of late-onset Alzheimer's disease and limbic NFT dementia

    Iseki E, Tsunoda S, Suzuki K et al. · Neuropathology : official journal of the Japanese Society of Neuropathology · 2002

  106. 0.82

    Cystatin C and apoe polymorphisms in Italian Alzheimer's disease

    Nacmias B, Bagnoli S, Tedde A et al. · Neuroscience letters · 2006

  107. 0.82

    Genetic association between Alzheimer disease and the alpha-synuclein gene

    Matsubara M, Yamagata H, Kamino K et al. · Dementia and geriatric cognitive disorders · 2001

  108. 0.82

    Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease

    Isbir T, Agachan B, Yilmaz H et al. · American journal of Alzheimer's disease and other dementias · 2001

  109. 0.82

    Association between presenilin 1 intronic polymorphism and late onset Alzheimer's disease in the North Chinese population

    Jia L, Zhou C, Lv H et al. · Brain research · 2006

  110. 0.81

    Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia

    Wehr H, Bednarska-Makaruk M, Lojkowska W et al. · Dementia and geriatric cognitive disorders · 2006

  111. 0.80

    Familial clustering and genetic risk for dementia in a genetically isolated Dutch population

    Sleegers K, Roks G, Theuns J et al. · Brain : a journal of neurology · 2004

  112. 0.80

    Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia

    Oliveira FFd, Chen ES, Smith MC et al. · Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2017

  113. 0.80

    Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele

    Pinhel MAS, Nakazone MA, Cacao JC et al. · Clinical chemistry and laboratory medicine · 2008

  114. 0.80

    Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease

    Bosco P, Gueant-Rodriguez RM, Anello G et al. · Journal of neurology, neurosurgery, and psychiatry · 2004

  115. 0.79

    Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease

    Anello G, Gueant-Rodriguez RM, Bosco P et al. · Neuroreport · 2004

  116. 0.79

    CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary

    Juhasz A, Rimanoczy A, Boda K et al. · Neurochemical research · 2005

  117. 0.79

    CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modification

    Cervilla JA, Russ C, Holmes C et al. · Biological psychiatry · 1999

  118. 0.79

    CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein epsilon4 and Cigarette Smoking

    Weng PH, Chen JH, Chen TF et al. · Scientific reports · 2016

  119. 0.79

    Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females

    Porrello E, Monti MC, Sinforiani E et al. · European journal of neurology · 2006

  120. 0.79

    Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study

    McCusker SM, Curran MD, Dynan KB et al. · Lancet (London, England) · 2001

  121. 0.79

    Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia

    Feher A, Juhasz A, Rimanoczy A et al. · Dementia and geriatric cognitive disorders · 2009

  122. 0.77

    A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease

    Bai H, Naj AC, Benchek P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  123. 0.77

    Lack of Association between Apolipoprotein E Polymorphism with Age at Onset of Subcortical Vascular Dementia

    Ryu HG, Youn SW, Kwon OD · Dementia and geriatric cognitive disorders extra · 2012

  124. 0.77

    A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease

    Papassotiropoulos A, Bagli M, Kurz A et al. · Annals of neurology · 2000

  125. 0.77

    Survival in Alzheimer's disease is shorter in women carrying heterozygosity at codon 129 of the PRNP gene and no APOE epsilon 4 allele

    Giannattasio C, Poleggi A, Puopolo M et al. · Dementia and geriatric cognitive disorders · 2008

  126. 0.76

    A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele

    Haasl RJ, Ahmadi MR, Meethal SV et al. · BMC medical genetics · 2008

  127. 0.76

    ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease

    Ahn Jo S, Ahn K, Kim JH et al. · Clinica chimica acta; international journal of clinical chemistry · 2006

  128. 0.76

    The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level

    Pesaresi M, Batelli S, Prato F et al. · Neurobiology of disease · 2007

  129. 0.76

    Association between the ABCG2 C421A polymorphism and Alzheimer's disease

    Feher A, Juhasz A, Laszlo A et al. · Neuroscience letters · 2013

  130. 0.76

    Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population

    Wijesinghe P, Shankar SK, Yasha TC et al. · Journal of Alzheimer's disease : JAD · 2016

  131. 0.76

    Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population

    Hatanaka Y, Kamino K, Fukuo K et al. · Clinical genetics · 2000

  132. 0.75

    Incidence of dementia in relation to genetic variants at PITX2, ZFHX3, and ApoE epsilon4 in atrial fibrillation patients

    Rollo J, Knight S, May HT et al. · Pacing and clinical electrophysiology : PACE · 2015

  133. 0.74

    Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease

    Nacmias B, Marcon G, Tedde A et al. · Neuroscience letters · 1998

  134. 0.74

    Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study

    Shaw P, Lerch JP, Pruessner JC et al. · The Lancet. Neurology · 2007

  135. 0.74

    Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task

    Ringman JM, Medina LD, Braskie M et al. · Cerebral cortex (New York, N.Y. : 1991) · 2011

  136. 0.74

    No mitochondrial haplotype was found to increase risk for Alzheimer's disease

    Zsurka G, Kalman J, Csaszar A et al. · Biological psychiatry · 1998

  137. 0.73

    Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease

    Brandi ML, Becherini L, Gennari L et al. · Biochemical and biophysical research communications · 1999

  138. 0.73

    APOE epsilon4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism

    Deo P, Dhillon VS, Chua A et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2020

  139. 0.73

    Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans RECODE

    Kim KW, Jhoo JH, Lee JH et al. · Neuroscience letters · 2001

  140. 0.73

    Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations

    Corbo RM, Gambina G, Ruggeri M et al. · Dementia and geriatric cognitive disorders · 2006

  141. 0.72

    Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity

    Nacmias B, Bagnoli S, Tedde A et al. · Archives of gerontology and geriatrics · 2007

  142. 0.72

    Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease

    Wiebusch H, Poirier J, Sevigny P et al. · Human genetics · 1999

  143. 0.72

    Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland

    McIlroy SP, Crawford VL, Dynan KB et al. · Journal of medical genetics · 2000

  144. 0.71

    TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels

    Laws SM, Perneczky R, Wagenpfeil S et al. · Human mutation · 2005

  145. 0.70

    The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease

    Brunelli T, Bagnoli S, Giusti B et al. · Neuroscience letters · 2001

  146. 0.69

    Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease

    Traykov L, Bayle AC, Latour F et al. · Journal of the neurological sciences · 2007

  147. 0.69

    HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study

    Alizadeh BZ, Njajou OT, Millan MR et al. · Neurobiology of aging · 2009

  148. 0.68

    Absence of association on aldehyde dehydrogenase 2 (ALDH2) polymorphism with Mongolian Alzheimer patients

    Zhou S, Huriletemuer, Wang J et al. · Neuroscience letters · 2010

  149. 0.68

    The paired immunoglobulin-like type 2 receptor alpha (PILRA) gene polymorphism rs1859788 reduces risk of Alzheimer's Disease in men homozygous for the ApoE epsilon4 allele

    Lehrer S, Rheinstein P · Research square · 2024

  150. 0.68

    TMEM106B is a selective modulator of TDP-43 pathology in Alzheimer's disease

    Reeves MM, Calliari A, Todd TW et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  151. 0.67

    APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage

    Nicoll JA, McCarron MO · Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2001

  152. 0.67

    Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism

    Rodriguez-Manotas M, Amorin-Diaz M, Canizares-Hernandez F et al. · Brain research · 2007

  153. 0.67

    Lack of association between apolipoprotein E polymorphism and vascular dementia in Koreans RECODE

    Kim KW, Youn JC, Han MK et al. · Journal of geriatric psychiatry and neurology · 2008

  154. 0.67

    Association of the HLA-A2 allele with an earlier age of onset of Alzheimer's disease

    Combarros O, Escribano J, Sanchez-Velasco P et al. · Acta neurologica Scandinavica · 1998

  155. 0.67

    Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population

    Ezquerra M, Blesa R, Tolosa E et al. · Neuroscience letters · 1998

  156. 0.66

    Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese Population

    Kawai E, Shibata N, Nagata T et al. · Neuromolecular medicine · 2015

  157. 0.66

    Abnormal Temporal Slowing on EEG Findings in Preclinical Alzheimer's Disease Patients With the ApoE4 Allele: A Pilot Study

    Kim NN, Tan C, Ma E et al. · Cureus · 2023

  158. 0.66

    No association between presenilin 1 (PS1) intronic polymorphism and sporadic Alzheimer's disease in Koreans RECODE

    Kim KW, Jhoo JH, Lee KU et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2000

  159. 0.65

    Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathology

    Iivonen S, Helisalmi S, Mannermaa A et al. · Neuroscience letters · 2003

  160. 0.65

    The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage

    McCarron MO, Nicoll JA, Stewart J et al. · Journal of neuropathology and experimental neurology · 1999

  161. 0.64

    No association of alpha1-antichymotrypsin flanking region polymorphism and Alzheimer disease risk in early- and late-onset Alzheimer disease patients

    Bass MP, Yamaoka LH, Scott WK et al. · Neuroscience letters · 1998

  162. 0.64

    Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population

    Bagli M, Papassotiropoulos A, Jessen F et al. · American journal of medical genetics · 2000

  163. 0.64

    A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease

    Tian J, Shi J, Bailey K et al. · Neuroscience letters · 2004

  164. 0.64

    Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease

    Yoshizawa T, Yamakawa-Kobayashi K, Hamaguchi H et al. · Journal of the neurological sciences · 1997

  165. 0.64

    Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease

    Yasuda M, Hirono N, Maeda K et al. · Journal of neurology, neurosurgery, and psychiatry · 1999

  166. 0.63

    Genetic assessment of apolipoprotein E polymorphism and PRNP genotypes in rapidly progressive dementias in Pakistan

    Rasheed U, Khalid M, Noor A et al. · Prion · 2024

  167. 0.63

    Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias

    Janka Z, Juhasz A, Rimanoczy A A et al. · Molecular psychiatry · 2002

  168. 0.62

    Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study

    Bonarek M, Barberger-Gateau P, Letenneur L et al. · Neuroepidemiology · 2000

  169. 0.62

    apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene

    Feuk L, Prince JA, Breen G et al. · Human genetics · 2000

  170. 0.61

    Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia

    Teijido O, Carril JC, Cacabelos R · Current genomics · 2017

  171. 0.60

    African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles

    Roses AD, Lutz MW, Saunders AM et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

  172. 0.60

    Serum 25-Hydroxyvitamin D, Vitamin D Receptor, and Vitamin-D-Binding Protein Gene Polymorphisms and Risk of Dementia Among Older Adults With Prediabetes

    Zhou C, Gan X, Ye Z et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2024

  173. 0.59

    The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis

    Ikram MA, Liu F, Oostra BA et al. · Biological psychiatry · 2009

  174. 0.59

    Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease

    Papassotiropoulos A, Bagli M, Jessen F et al. · Molecular psychiatry · 2000

  175. 0.59

    Association between angiotensin-converting enzyme and Alzheimer disease

    Farrer LA, Sherbatich T, Keryanov SA et al. · Archives of neurology · 2000

  176. 0.58

    Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

    Du Y, Dodel RC, Eastwood BJ et al. · Neurology · 2000

  177. 0.58

    Estrogen receptor polymorphisms and incident dementia: the prospective 3C study

    Ryan J, Carriere I, Carcaillon L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

  178. 0.58

    Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease

    Bagnoli S, Nacmias B, Tedde A et al. · Neuroscience letters · 2002

  179. 0.58

    Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease

    Blesa R, Aguilar M, Casanova JP et al. · Alzheimer disease and associated disorders · 2006

  180. 0.57

    Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma

    Zetterberg M, Tasa G, Palmer MS et al. · American journal of ophthalmology · 2007

  181. 0.57

    Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms

    Zappia M, Manna I, Serra P et al. · Archives of neurology · 2004

  182. 0.57

    Non-replication of association between cathepsin D genotype and late onset Alzheimer disease

    Menzer G, Muller-Thomsen T, Meins W et al. · American journal of medical genetics · 2001

  183. 0.56

    Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease

    Flex A, Gaetani E, Proia AS et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006

  184. 0.56

    Association study of cathepsin D gene polymorphism in Iranian patients with sporadic late-onset Alzheimer's disease

    Sayad A, Noruzinia M, Zamani M et al. · Dementia and geriatric cognitive disorders · 2014

  185. 0.56

    Alpha-1-antichymotrypsin is not associated with the increased frequency of apolipoprotein-E-epsilon-4 allele in elderly non-demented leprosy patients

    Endoh M, Ueki A, Takahashi K et al. · Dementia and geriatric cognitive disorders · 1998

  186. 0.56

    Risk factors for cerebral amyloid angiopathy in the elderly

    Yamada M · Annals of the New York Academy of Sciences · 2002

  187. 0.55

    No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans RECODE

    Kim KW, Jhoo JH, Lee KU et al. · American journal of medical genetics · 2000

  188. 0.55

    No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population

    Monastero R, Camarda C, Cefalu AB et al. · Journal of Alzheimer's disease : JAD · 2005

  189. 0.55

    Apolipoprotein E polymorphism and behavioral and psychological symptoms of dementia in patients with Alzheimer disease

    Chen CS, Ouyang P, Yeh YC et al. · Alzheimer disease and associated disorders · 2012

  190. 0.55

    Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors

    Huang F, Shang Y, Luo Y et al. · Journal of Alzheimer's disease : JAD · 2016

  191. 0.55

    Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage

    McCarron MO, Nicoll JA · Annals of the New York Academy of Sciences · 2000

  192. 0.55

    Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis

    Zhou Q, Zhao F, Lv Zp et al. · PloS one · 2014

  193. 0.54

    Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease

    Nacmias B, Tedde A, Cellini E et al. · Neuroscience letters · 2001

  194. 0.54

    Methylenetetrahydrofolate reductase gene and risk of Alzheimer's disease in Koreans

    Kim JM, Stewart R, Kim SW et al. · International journal of geriatric psychiatry · 2008

  195. 0.54

    Characterization of APOE and TOMM40 allele frequencies in the Japanese population

    Nishimura A, Nonomura H, Tanaka S et al. · Alzheimer's & dementia (New York, N. Y.) · 2017

  196. 0.54

    CYP46A1 T/C polymorphism associated with the APOE epsilon4 allele increases the risk of Alzheimer's disease

    Li L, Yin Z, Liu J et al. · Journal of neurology · 2013

  197. 0.53

    APOE gene polymorphism analysis in Barranquilla, Colombia

    Ruiz M, Arias I, Rolon G et al. · Biomedica : revista del Instituto Nacional de Salud · 2016

  198. 0.53

    Cystatin C as a risk factor for Alzheimer disease

    Cathcart HM, Huang R, Lanham IS et al. · Neurology · 2005

  199. 0.53

    Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants

    Bruno D, Nierenberg JJ, Ritchie JC et al. · Psychoneuroendocrinology · 2012

  200. 0.53

    Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease

    Bi XH, Zhao HL, Zhang ZX et al. · Neurobiology of aging · 2009

  201. 0.53

    Genetic polymorphisms of lipid metabolism gene SAR1 homolog B and the risk of Alzheimer's disease and vascular dementia

    Chen JH, Hsieh CJ, Huang YL et al. · Journal of the Formosan Medical Association = Taiwan yi zhi · 2016

  202. 0.53

    Interleukin-1alpha, interleukin-1beta and tumor necrosis factor-alpha genetic variants and risk of dementia in the very old: evidence from the "Monzino 80-plus" prospective study

    Albani D, Tettamanti M, Batelli S et al. · Age (Dordrecht, Netherlands) · 2012

  203. 0.52

    Characterization of the poly-T variant in the TOMM40 gene in diverse populations

    Linnertz C, Saunders AM, Lutz MW et al. · PloS one · 2012

  204. 0.52

    The genetic studies of dementias in Taiwan

    Chen HH, Hu CJ · Acta neurologica Taiwanica · 2006

  205. 0.51

    APOE and cerebral amyloid angiopathy in community-dwelling older persons

    Yu L, Boyle PA, Nag S et al. · Neurobiology of aging · 2015

  206. 0.51

    Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases

    Itabashi S, Arai H, Matsui T et al. · Experimental neurology · 1998

  207. 0.51

    Mitochondrial haplogroup H and Alzheimer's disease--is there a connection?

    Maruszak A, Canter JA, Styczynska M et al. · Neurobiology of aging · 2009

  208. 0.50

    Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study

    Katsuya T, Baba S, Ishikawa K et al. · Journal of hypertension · 2002

  209. 0.50

    Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births

    Bhaumik P, Ghosh P, Ghosh S et al. · Genetics and molecular biology · 2017

  210. 0.50

    Low apolipoprotein E epsilon4 allele frequency in the population of Catalonia (Spain) determined by PCR-RFLP and Laser fluorescent sequencer

    Gene M, Moreno P, Ezquerra M et al. · European journal of epidemiology · 1997

02cognitive · impairment166편

  1. 0.96

    Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study

    Tsolaki AC, Gatzima O, Daniilidou M et al. · Neuro-degenerative diseases · 2018

  2. 0.94

    A Cross-Sectional Analysis of APOE Gene Polymorphism and the Risk of Cognitive Impairments in the Alzheimer's Disease Neuroimaging Initiative Study

    Wang G, Vance DE, Li W · JAR life · 2021

  3. 0.93

    APOE varepsilon4, rs405509, and rs440446 promoter and intron-1 polymorphisms and dementia risk in a cohort of elderly Finns-Helsinki Birth Cohort Study

    Rantalainen V, Lahti J, Kajantie E et al. · Neurobiology of aging · 2019

  4. 0.93

    Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population

    Yip AG, Brayne C, Easton D et al. · Journal of medical genetics · 2002

  5. 0.92

    Risk factors for dementia of Alzheimer type and aging-associated cognitive decline in a Spanish population based sample, and in brains with pathology confirmed Alzheimer's disease

    Ampuero I, Ros R, Royuela A et al. · Journal of Alzheimer's disease : JAD · 2008

  6. 0.92

    Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients

    Zill P, Engel R, Hampel H et al. · European archives of psychiatry and clinical neuroscience · 2001

  7. 0.92

    Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators

    Borroni B, Archetti S, Agosti C et al. · Neurobiology of aging · 2004

  8. 0.91

    Is there a significant interaction effect between apolipoprotein E rs405509 T/T and epsilon4 genotypes on cognitive impairment and gray matter volume?

    Ma C, Zhang Y, Li X et al. · European journal of neurology · 2016

  9. 0.91

    APOEvarepsilon4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease

    Cardoso R, Lemos C, Oliveiros B et al. · Journal of Alzheimer's disease : JAD · 2020

  10. 0.91

    Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease

    Traykov L, Rigaud AS, Caputo L et al. · European journal of neurology · 1999

  11. 0.91

    APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss

    Laws SM, Clarnette RM, Taddei K et al. · Molecular psychiatry · 2002

  12. 0.90

    ApoE Genotype, Age, and Cognitive Decline in Old Chinese Individuals Without Dementia: A Population-Based Study With Five-Year Follow-Up

    Wu H, Gu X, Liu S et al. · International journal of geriatric psychiatry · 2025

  13. 0.90

    Apolipoprotein E genotype and cognitive impairment in community-dwelling black older adults

    Harwood DG, Barker WW, Ownby RL et al. · International journal of psychiatry in medicine · 2002

  14. 0.90

    Apolipoprotein E polymorphism and cognitive impairment in a bi-ethnic community-dwelling elderly sample

    Harwood DG, Barker WW, Ownby RL et al. · Alzheimer disease and associated disorders · 2002

  15. 0.90

    Correlation of polymorphism of APOE and LRP genes to cognitive impairment and behavioral and psychological symptoms of dementia in Alzheimer's disease and vascular dementia

    Mou C, Han T, Wang M et al. · International journal of clinical and experimental medicine · 2015

  16. 0.90

    Frequency of the apolipoprotein E epsilon4 allele in a memory clinic cohort in Beijing: a naturalistic descriptive study

    Wang X, Wang H, Li H et al. · PloS one · 2014

  17. 0.90

    APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease

    Barabash A, Marcos A, Ancin I et al. · Neurobiology of aging · 2009

  18. 0.89

    Relationship Between Apolipoprotein E Genotypes, Unhealthy Weight Status, and Cognitive Impairment in Older Adults of Predominantly African Descent

    Clotilde JP, Nicolas L, Larifla L et al. · Diseases (Basel, Switzerland) · 2025

  19. 0.89

    APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease

    Zhou Q, Peng D, Yuan X et al. · Neural regeneration research · 2014

  20. 0.89

    Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene

    Elcoroaristizabal Martin X, Fernandez Martinez M, Galdos Alcelay L et al. · Dementia and geriatric cognitive disorders · 2011

  21. 0.88

    Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease

    Morgen K, Ramirez A, Frolich L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

  22. 0.88

    Apolipoprotein E alleles in Cuban patients with mild cognitive impairment

    Suarez VM, Fernandez Y, Lopez EdCR et al. · American journal of Alzheimer's disease and other dementias · 2014

  23. 0.87

    Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease

    Jack CRJ, Petersen RC, Xu YC et al. · Annals of neurology · 1998

  24. 0.87

    Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment

    Chico L, Simoncini C, Lo Gerfo A et al. · Free radical research · 2013

  25. 0.87

    Effect of APOE and CD33 on Cognitive Decline

    Hayden KM, Lutz MW, Kuchibhatla M et al. · PloS one · 2015

  26. 0.87

    The TT allele of rs405509 synergizes with APOE epsilon4 in the impairment of cognition and its underlying default mode network in non-demented elderly

    Ma C, Zhang Y, Li X et al. · Current Alzheimer research · 2016

  27. 0.87

    Synergistic Effects of APOE and CLU May Increase the Risk of Alzheimer's Disease: Acceleration of Atrophy in the Volumes and Shapes of the Hippocampus and Amygdala

    An N, Fu Y, Shi J et al. · Journal of Alzheimer's disease : JAD · 2021

  28. 0.86

    Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease

    Spampinato MV, Langdon BR, Patrick KE et al. · Neuroradiology · 2016

  29. 0.86

    The GAB2 and BDNF polymorphisms and the risk for late-onset Alzheimer's disease in an elderly Brazilian sample

    Vieira RN, Magalhaes JD, Sant'Anna J et al. · International psychogeriatrics · 2015

  30. 0.86

    Influence of ApoE Genotype and Clock T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer's Disease in Subjective Cognitive Decline and Mild Cognitive Impairment Patients

    Bessi V, Balestrini J, Bagnoli S et al. · Journal of personalized medicine · 2020

  31. 0.86

    Telomere length and ApoE polymorphism in mild cognitive impairment, degenerative and vascular dementia

    Zekry D, Herrmann FR, Irminger-Finger I et al. · Journal of the neurological sciences · 2010

  32. 0.85

    Association between Alzheimer's disease genes and trajectories of cognitive function decline in Han Chinese in Taiwan

    Hsieh TJ, Lee WJ, Liao YC et al. · Aging · 2021

  33. 0.85

    Genetic variation in APOE cluster region and Alzheimer's disease risk

    Cervantes S, Samaranch L, Vidal-Taboada JM et al. · Neurobiology of aging · 2011

  34. 0.85

    Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism

    Donix M, Burggren AC, Suthana NA et al. · NeuroImage · 2010

  35. 0.85

    Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOEepsilon4 Allele

    Gamarra D, Elcoroaristizabal X, Fernandez-Martinez M et al. · Disease markers · 2015

  36. 0.85

    APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment

    Dixon RA, DeCarlo CA, MacDonald SWS et al. · Frontiers in aging neuroscience · 2014

  37. 0.85

    Are APOE varepsilon genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?

    Lyall DM, Harris SE, Bastin ME et al. · Translational psychiatry · 2014

  38. 0.84

    Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients

    Lanni C, Garbin G, Lisa A et al. · Journal of Alzheimer's disease : JAD · 2012

  39. 0.83

    Association of genetic risk factors with cognitive decline: the PATH through life project

    Andrews SJ, Das D, Cherbuin N et al. · Neurobiology of aging · 2016

  40. 0.83

    A candidate gene study of risk for dementia in older, postmenopausal women: Results from the Women's Health Initiative Memory Study

    Driscoll I, Snively BM, Espeland MA et al. · International journal of geriatric psychiatry · 2019

  41. 0.83

    Genetic determinants of "cognitive impairment, no dementia"

    Dube JB, Johansen CT, Robinson JF et al. · Journal of Alzheimer's disease : JAD · 2013

  42. 0.82

    The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes

    D'Onofrio G, Panza F, Seripa D et al. · International journal of geriatric psychiatry · 2011

  43. 0.82

    Alzheimer's disease: genetic polymorphisms and rate of decline

    Schmidt C, Wolff M, von Ahsen N et al. · Dementia and geriatric cognitive disorders · 2012

  44. 0.82

    Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease

    Hashimoto R, Hirata Y, Asada T et al. · Genes, brain, and behavior · 2009

  45. 0.82

    Effects of APOE promoter polymorphism on the topological organization of brain structural connectome in nondemented elderly

    Shu N, Li X, Ma C et al. · Human brain mapping · 2015

  46. 0.82

    Modification of estrogen's association with Alzheimer's disease risk by genetic polymorphisms

    Thornton V, Warden D, Talbot C et al. · Brain research · 2011

  47. 0.81

    Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study

    Andrews SJ, Das D, Anstey KJ et al. · Journal of Alzheimer's disease : JAD · 2017

  48. 0.81

    Association of Butyrylcholinesterase-K Allele and Apolipoprotein E varepsilon4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease

    Vijayaraghavan S, Darreh-Shori T, Rongve A et al. · Journal of Alzheimer's disease : JAD · 2016

  49. 0.80

    Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer's Disease

    Mosca A, Sperduti S, Pop V et al. · Frontiers in aging neuroscience · 2018

  50. 0.80

    Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study

    Vivot A, Glymour MM, Tzourio C et al. · Molecular psychiatry · 2015

  51. 0.80

    The role of epsilon phenotype in brain glucose consumption in Alzheimer's disease

    Ricci M, Chiaravalloti A, Martorana A et al. · Annals of nuclear medicine · 2020

  52. 0.79

    Analysis of cognitive performance and polymorphisms of SORL1, PVRL2, CR1, TOMM40, APOE, PICALM, GWAS_14q, CLU, and BIN1 in patients with mild cognitive impairment and cognitively healthy controls

    Cruz-Sanabria F, Bonilla-Vargas K, Estrada K et al. · Neurologia · 2018

  53. 0.79

    Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE epsilon4 Allele in Alzheimer's Disease

    Babic Leko M, Nikolac Perkovic M, Nedic Erjavec G et al. · Current Alzheimer research · 2021

  54. 0.79

    APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921

    Schiepers OJG, Harris SE, Gow AJ et al. · Molecular psychiatry · 2012

  55. 0.79

    Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment

    Religa D, Styczynska M, Peplonska B et al. · Dementia and geriatric cognitive disorders · 2003

  56. 0.79

    The Effects of an APOE Promoter Polymorphism on Human White Matter Connectivity during Non-Demented Aging

    Chang P, Li X, Ma C et al. · Journal of Alzheimer's disease : JAD · 2017

  57. 0.78

    APOE-epsilon4 polymorphism and cognitive deficit among the elderly population of Fernando de Noronha

    Garcia AN, Silva HAd, Silva RC et al. · Arquivos de neuro-psiquiatria · 2008

  58. 0.78

    Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

    Drzezga A, Grimmer T, Henriksen G et al. · Neurology · 2009

  59. 0.78

    Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities

    Bartres-Faz D, Junque C, Lopez-Alomar A et al. · Journal of the American Geriatrics Society · 2001

  60. 0.78

    Genetic Predisposition to Alzheimer's Disease Is Associated with Enlargement of Perivascular Spaces in Centrum Semiovale Region

    Ciampa I, Operto G, Falcon C et al. · Genes · 2021

  61. 0.78

    A study on the correlation between APOE gene polymorphism, white matter hyperintensities, and neuropsychiatric symptom phenotypes in Alzheimer's disease

    Fan W, Wang Z, Wan S et al. · Frontiers in psychiatry · 2026

  62. 0.77

    Polymorphism of brain derived neurotrophic factor influences beta amyloid load in cognitively intact apolipoprotein E epsilon4 carriers

    Adamczuk K, De Weer AS, Nelissen N et al. · NeuroImage. Clinical · 2013

  63. 0.77

    Analysis of cognitive performance and polymorphisms of SORL1, PVRL2, CR1, TOMM40, APOE, PICALM, GWAS_14q, CLU, and BIN1 in patients with mild cognitive impairment and cognitively healthy controls

    Cruz-Sanabria F, Bonilla-Vargas K, Estrada K et al. · Neurologia · 2021

  64. 0.77

    Association of ApoE epsilon4 allele, homocysteine, and inflammatory factors (hs-CRP, IL-6, TNF-alpha) with cognitive dysfunction in Alzheimer's disease patients and development and validation of a predictive model

    Wang L, Sun Q · Neurological research · 2026

  65. 0.77

    Genetic Stratification to Identify Risk Groups for Alzheimer's Disease

    Marioni RE, Campbell A, Hagenaars SP et al. · Journal of Alzheimer's disease : JAD · 2017

  66. 0.76

    From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up

    Siuda J, Gorzkowska A, Patalong-Ogiewa M et al. · Neurologia i neurochirurgia polska · 2009

  67. 0.76

    Predictability of polygenic risk score for progression to dementia and its interaction with APOE epsilon4 in mild cognitive impairment

    Pyun JM, Park YH, Lee KJ et al. · Translational neurodegeneration · 2021

  68. 0.76

    Longitudinal cognitive decline in the AIBL cohort: The role of APOE epsilon4 status

    Albrecht MA, Szoeke C, Maruff P et al. · Neuropsychologia · 2015

  69. 0.76

    Apolipoprotein E e4 and Cognitive Function: A Modifiable Association Results from Two Independent Cohort Studies

    Perna L, Mons U, Rujescu D et al. · Dementia and geriatric cognitive disorders · 2016

  70. 0.75

    Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention

    Engelman CD, Koscik RL, Jonaitis EM et al. · Journal of Alzheimer's disease : JAD · 2013

  71. 0.75

    Apolipoprotein E genotype moderates the association between dietary polyunsaturated fat and brain function: an exploration of cerebral glutamate and cognitive performance

    Oleson S, Eagan D, Kaur S et al. · Nutritional neuroscience · 2020

  72. 0.75

    Distinct neural correlates of episodic memory among apolipoprotein E alleles in cognitively normal elderly

    Shu H, Shi Y, Chen G et al. · Brain imaging and behavior · 2019

  73. 0.75

    A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEvarepsilon4 Carriers

    Sapkota S, Dixon RA · Journal of Alzheimer's disease : JAD · 2018

  74. 0.74

    Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia

    Mehta K, Mohebbi M, Pasco JA et al. · Scientific reports · 2022

  75. 0.74

    Saccade latency delays in young apolipoprotein E (APOE) epsilon 4 carriers

    Niechwiej-Szwedo E, Tapper A, Gonzalez D et al. · Behavioural brain research · 2018

  76. 0.74

    Exploring candidate gene associations with neuropsychological performance

    McQueen MB, Bertram L, Lange C et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2007

  77. 0.74

    Polymorphisms of apolipoprotein E gene and cognitive functions of postmenopausal women, measured by battery of computer tests - Central Nervous System Vital Signs

    Bojar I, Wojcik-Fatla A, Owoc A et al. · Neuro endocrinology letters · 2012

  78. 0.73

    Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment

    Cechova K, Andel R, Angelucci F et al. · Journal of Alzheimer's disease : JAD · 2020

  79. 0.73

    Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study

    Bressler J, Mosley TH, Penman A et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017

  80. 0.72

    Genetic Risk Score Predicts Late-Life Cognitive Impairment

    Wollam ME, Weinstein AM, Saxton JA et al. · Journal of aging research · 2015

  81. 0.72

    Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease

    Villemagne VL, Pike KE, Chetelat G et al. · Annals of neurology · 2011

  82. 0.72

    Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men

    Panizzon MS, Hauger R, Dale AM et al. · Neurology · 2010

  83. 0.72

    The relationship between cortisol and cognitive function in healthy older people: The moderating role of Apolipoprotein E polymorphism

    Montoliu T, Hidalgo V, Pulopulos MM et al. · Neurobiology of learning and memory · 2018

  84. 0.72

    The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers

    Martinez MF, Martin XE, Alcelay LG et al. · BMC neuroscience · 2009

  85. 0.71

    Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment

    Forlenza OV, Diniz BS, Teixeira AL et al. · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2010

  86. 0.71

    Apolipoprotein E4 and brain white matter integrity in Alzheimer's disease: tract-based spatial statistics study under 3-Tesla MRI

    Bagepally BS, Halahalli HN, John JP et al. · Neuro-degenerative diseases · 2012

  87. 0.71

    Lack of reliable evidence for a distinctive epsilon4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study

    Foster JK, Albrecht MA, Savage G et al. · Brain : a journal of neurology · 2013

  88. 0.71

    High homocysteine and epistasis between MTHFR and APOE: association with cognitive performance in the elderly

    Polito L, Poloni TE, Vaccaro R et al. · Experimental gerontology · 2016

  89. 0.71

    Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults

    Flory JD, Manuck SB, Ferrell RE et al. · American journal of medical genetics · 2000

  90. 0.71

    Source analysis of spontaneous magnetoencephalograpic activity in healthy aging and mild cognitive impairment: influence of apolipoprotein E polymorphism

    Cuesta P, Barabash A, Aurtenetxe S et al. · Journal of Alzheimer's disease : JAD · 2015

  91. 0.70

    The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort

    Jacobson AM, Paterson AD, Ryan CM et al. · Diabetic medicine : a journal of the British Diabetic Association · 2010

  92. 0.70

    Differential Effects of APOE Genotypes on the Anterior and Posterior Subnetworks of Default Mode Network in Amnestic Mild Cognitive Impairment

    Yuan B, Xie C, Shu H et al. · Journal of Alzheimer's disease : JAD · 2016

  93. 0.70

    Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

    Espinosa A, Hernandez-Olasagarre B, Moreno-Grau S et al. · Frontiers in aging neuroscience · 2018

  94. 0.70

    Influence of Alzheimer's disease genes on cognitive decline: the Guangzhou Biobank Cohort Study

    Gui H, Jiang CQ, Cherny SS et al. · Neurobiology of aging · 2014

  95. 0.69

    The association of APOE genotype with cognitive function in persons aged 35 years or older

    Izaks GJ, Gansevoort RT, van der Knaap AM et al. · PloS one · 2011

  96. 0.69

    Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study

    Sakurai R, Montero-Odasso M · The journals of gerontology. Series A, Biological sciences and medical sciences · 2017

  97. 0.69

    Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework

    Ning K, Chen B, Sun F et al. · Neurobiology of aging · 2018

  98. 0.68

    Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment

    Thomann PA, Roth AS, Dos Santos V et al. · Dementia and geriatric cognitive disorders · 2008

  99. 0.68

    Late-Onset Alzheimer's Disease Polygenic Risk Profile Score Predicts Hippocampal Function

    Xiao E, Chen Q, Goldman AL et al. · Biological psychiatry. Cognitive neuroscience and neuroimaging · 2017

  100. 0.68

    Exploring the interaction of APOE-epsilon4and PICALM rs3851179 with dynamic functional connectivity in healthy middle-aged adults at risk for Alzheimer's disease

    Dharia SY, Valderrama CE, Liu Q et al. · Journal of neural engineering · 2026

  101. 0.68

    Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms

    Matuskova V, Veverova K, Jester DJ et al. · Alzheimer's research & therapy · 2024

  102. 0.67

    Association of SORL1 polymorphisms and SORL1-APOE epsilon4 interaction with risk of subjective cognitive decline and mild cognitive impairment in the Chinese population

    Meng F, Zhao T, Yang X et al. · Journal of Alzheimer's disease : JAD · 2026

  103. 0.67

    Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer's Disease

    de Oliveira FF, Chen ES, Smith MC et al. · Journal of molecular neuroscience : MN · 2020

  104. 0.67

    Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

    Lacour A, Espinosa A, Louwersheimer E et al. · Molecular psychiatry · 2017

  105. 0.67

    Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population

    Payton A, van den Boogerd E, Davidson Y et al. · Genes, brain, and behavior · 2006

  106. 0.67

    Mid age APOE epsilon4 carriers show memory-related functional differences and disrupted structure-function relationships in hippocampal regions

    Evans SL, Dowell NG, Prowse F et al. · Scientific reports · 2020

  107. 0.66

    Mapping of ApoE4 Related White Matter Damage using Diffusion MRI

    Tsao S, Gajawelli N, Hwang DH et al. · Proceedings of SPIE--the International Society for Optical Engineering · 2014

  108. 0.65

    The link between static and dynamic brain functional network connectivity and genetic risk of Alzheimer's disease

    Sendi MSE, Zendehrouh E, Ellis CA et al. · NeuroImage. Clinical · 2023

  109. 0.65

    Exploiting Drug-Apolipoprotein E Gene Interactions in Hypertension to Preserve Cognitive Function: The 3-City Cohort Study

    Tully PJ, Helmer C, Peters R et al. · Journal of the American Medical Directors Association · 2019

  110. 0.65

    Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936

    Lyall DM, Harris SE, Bastin ME et al. · Neurobiology of aging · 2014

  111. 0.65

    APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset

    Rabipour S, Rajagopal S, Yu E et al. · Journal of Alzheimer's disease : JAD · 2020

  112. 0.64

    Genetic modifiers of APOE-epsilon4-associated cognitive decline

    Contreras AG, Walters S, Eissman JM et al. · Nature communications · 2026

  113. 0.64

    The Role of ApoE Polymorphism in the Relationship between Serum Steroid Hormone Levels and Cognition in Older Chinese Adults: A Cross-Sectional Study

    Huang X, Dong S, Zhen J et al. · Frontiers in endocrinology · 2018

  114. 0.64

    Leukocyte telomere attrition in cognitive decline: associations with APOE genotype and cardiovascular risk factors

    Barros AGdA, Soares TO, Lage AFA et al. · Frontiers in aging neuroscience · 2025

  115. 0.64

    Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease

    Andersson ME, Sjolander A, Andreasen N et al. · International journal of molecular medicine · 2007

  116. 0.64

    Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease

    Gabriel AJ, Almeida MR, Ribeiro MH et al. · Journal of Alzheimer's disease : JAD · 2018

  117. 0.64

    Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease

    Fernandez Del Pozo V, Alvarez Alvarez M, Fernandez Martinez M et al. · Dementia and geriatric cognitive disorders · 2006

  118. 0.64

    Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein epsilon4 on memory decline in older adults

    Sundermann EE, Wang C, Katz M et al. · Neurobiology of aging · 2016

  119. 0.64

    APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults

    Ward DD, Summers MJ, Saunders NL et al. · Behavioural brain research · 2014

  120. 0.63

    Altered memory-related functional connectivity of the anterior and posterior hippocampus in older adults at increased genetic risk for Alzheimer's disease

    Harrison TM, Burggren AC, Small GW et al. · Human brain mapping · 2016

  121. 0.63

    CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner

    Murphy EA, Roddey JC, McEvoy LK et al. · Brain imaging and behavior · 2012

  122. 0.63

    APOE polymorphism affects episodic memory among non demented elderly subjects

    De Blasi S, Montesanto A, Martino C et al. · Experimental gerontology · 2009

  123. 0.63

    The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume

    Lupton MK, Strike L, Hansell NK et al. · Neurobiology of aging · 2016

  124. 0.63

    Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE varepsilon4 carriers: a case-control study

    Fernandez-Martinez M, Elcoroaristizabal Martin X, Blanco Martin E et al. · BMJ open · 2013

  125. 0.63

    Dopamine Receptor Genes Modulate Associative Memory in Old Age

    Papenberg G, Becker N, Ferencz B et al. · Journal of cognitive neuroscience · 2017

  126. 0.63

    A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism

    Lehtovirta M, Partanen J, Kononen M et al. · Dementia and geriatric cognitive disorders · 2000

  127. 0.63

    Association and interaction effects of Alzheimer's disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population

    Lin E, Tsai SJ, Kuo PH et al. · Oncotarget · 2017

  128. 0.63

    A Multimodal Risk Network Predicts Executive Function Trajectories in Non-demented Aging

    Sapkota S, McFall GP, Masellis M et al. · Frontiers in aging neuroscience · 2021

  129. 0.62

    UBQ-8i polymorphism is not an independent risk factor for mild cognitive impairment and Alzheimer's disease in APOE-4 carriers

    Martin XE, Martinez MF, Fernandez DG et al. · Current Alzheimer research · 2012

  130. 0.62

    The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3/epsilon3 genotype

    Johnson SC, La Rue A, Hermann BP et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2011

  131. 0.62

    Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men

    Plourde M, Vohl MC, Vandal M et al. · The British journal of nutrition · 2009

  132. 0.62

    Homozygosity in the ApoE 4 polymorphism is associated with dysphagic symptoms in older adults

    Mentz H, Horan M, Payton A et al. · Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2015

  133. 0.62

    Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia

    Calm B, Hinojosa-Calleja A, Garcia-Gutierrez F et al. · The journal of prevention of Alzheimer's disease · 2026

  134. 0.61

    The association of Alzheimer's disease-related SNPs with mild cognitive impairment susceptibility in the Chinese population

    Xie Z, Tu W, Ye XF et al. · Scientific reports · 2026

  135. 0.61

    APOE-MS4A genetic interactions are associated with executive dysfunction and network abnormality in clinically mild Alzheimer's disease

    Chang YT, Mori E, Suzuki M et al. · NeuroImage. Clinical · 2019

  136. 0.61

    Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

    Louwersheimer E, Wolfsgruber S, Espinosa A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016

  137. 0.60

    HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study

    Leduc V, De Beaumont L, Theroux L et al. · Molecular psychiatry · 2015

  138. 0.60

    Sex differences in genetic modifiers of traumatic brain injury and late-life cognitive decline: the Cache County study

    Drewel MA, Schwartz S, Rattinger GB et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026

  139. 0.60

    Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s

    Logue MW, Panizzon MS, Elman JA et al. · Molecular psychiatry · 2019

  140. 0.60

    Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease

    Pihlajamaki M, O' Keefe K, Bertram L et al. · Alzheimer disease and associated disorders · 2010

  141. 0.59

    KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE epsilon4-positive cognitively normal adults with high Abeta-amyloid burden

    Porter T, Burnham SC, Dore V et al. · Scientific reports · 2018

  142. 0.59

    Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI

    Mukherjee S, Trittschuh E, Gibbons LE et al. · Brain imaging and behavior · 2012

  143. 0.59

    The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades

    Alexander DM, Williams LM, Gatt JM et al. · Biological psychology · 2007

  144. 0.59

    Breast Cancer, Alzheimer's Disease, and APOE4 Allele in the UK Biobank Cohort

    Lehrer S, Rheinstein PH · Journal of Alzheimer's disease reports · 2021

  145. 0.58

    Both odor identification and ApoE-epsilon4 contribute to normative cognitive aging

    Finkel D, Reynolds CA, Larsson M et al. · Psychology and aging · 2011

  146. 0.57

    Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study

    Grunblatt E, Zehetmayer S, Bartl J et al. · Journal of psychiatric research · 2009

  147. 0.57

    The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age

    Ferencz B, Laukka EJ, Lovden M et al. · Frontiers in human neuroscience · 2013

  148. 0.57

    Small-World Networks and Their Relationship With Hippocampal Glutamine/Glutamate Concentration in Healthy Adults With Varying Genetic Risk for Alzheimer's Disease

    Zhang H, Chiu PW, Ip I et al. · Journal of magnetic resonance imaging : JMRI · 2021

  149. 0.56

    Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?

    Persson J, Lind J, Larsson A et al. · Neurology · 2006

  150. 0.56

    APOE4 protects the cognitive development in children with heavy diarrhea burdens in Northeast Brazil

    Oria RB, Patrick PD, Zhang H et al. · Pediatric research · 2005

  151. 0.56

    Association of multiple candidate genes with mild cognitive impairment in an elderly Chinese Uygur population in Xinjiang

    Zou T, Chen W, Zhou X et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2019

  152. 0.55

    Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms

    Borroni B, Grassi M, Agosti C et al. · Neurobiology of aging · 2006

  153. 0.55

    APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years

    Taylor JL, Scanlon BK, Farrell M et al. · Neurobiology of aging · 2014

  154. 0.54

    An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Abeta1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients

    Sun Y, Bresell A, Rantalainen M et al. · Journal of Alzheimer's disease : JAD · 2015

  155. 0.54

    ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with Hyperlipidemia

    Machowska M, Leszek J, Raczy-Krzemianowska M et al. · International journal of molecular sciences · 2025

  156. 0.53

    Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data

    Kong D, Giovanello KS, Wang Y et al. · Journal of Alzheimer's disease : JAD · 2015

  157. 0.53

    Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population

    Omoumi A, Fok A, Greenwood T et al. · Neurobiology of aging · 2014

  158. 0.53

    The benefits of staying active in old age: physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning

    Ferencz B, Laukka EJ, Welmer AK et al. · Psychology and aging · 2014

  159. 0.52

    Atheromatosis extent in coronary artery disease is not correlated with apolipoprotein-E polymorphism and its plasma levels, but associated with cognitive decline

    Lima LM, Carvalho MdG, Ferreira CN et al. · Current Alzheimer research · 2010

  160. 0.52

    The deletion variant of alpha2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment

    Koutroumani M, Daniilidou M, Giannakouros T et al. · Journal of the neurological sciences · 2013

  161. 0.52

    Multilocus genetic profiling to empower drug trials and predict brain atrophy

    Kohannim O, Hua X, Rajagopalan P et al. · NeuroImage. Clinical · 2013

  162. 0.51

    Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms

    Soares JZ, Pettersen R, Benth JS et al. · Journal of Alzheimer's disease : JAD · 2021

  163. 0.50

    The apolipoprotein E gene, attention, and brain function

    Parasuraman R, Greenwood PM, Sunderland T · Neuropsychology · 2002

  164. 0.50

    Association between ApoE epsilon4 Carrier Status and Cardiovascular Risk Factors on Mild Cognitive Impairment among Mexican Older Adults

    Aguilar-Navarro SG, Gonzalez-Aparicio II, Avila-Funes JA et al. · Brain sciences · 2021

  165. 0.50

    Tract Based Spatial Statistic Reveals No Differences in White Matter Microstructural Organization between Carriers and Non-Carriers of the APOE varepsilon4 and varepsilon2 Alleles in Young Healthy Adolescents

    Dell'Acqua F, Khan W, Gottlieb N et al. · Journal of Alzheimer's disease : JAD · 2015

  166. 0.50

    APOE-epsilon4 selectively modulates posteromedial cortex activity during scene perception and short-term memory in young healthy adults

    Shine JP, Hodgetts CJ, Postans M et al. · Scientific reports · 2015

03genome-wide · loci154편

  1. 0.94

    Next-generation sequencing study identifies the first genes associated with Alzheimer's disease in Bangladeshi population: The CARED study

    Hakim M, Ranjan R, Ken-Dror G et al. · Journal of Alzheimer's disease : JAD · 2026

  2. 0.94

    APOE and dementia - resequencing and genotyping in 105,597 individuals

    Rasmussen KL, Tybjaerg-Hansen A, Nordestgaard BG et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020

  3. 0.94

    Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk

    Kulminski AM, Philipp I, Shu L et al. · Neurobiology of aging · 2022

  4. 0.93

    Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer's disease risk

    Aslam MM, Fan KH, Lawrence E et al. · Molecular psychiatry · 2023

  5. 0.92

    Comprehensive search for Alzheimer disease susceptibility loci in the APOE region

    Jun G, Vardarajan BN, Buros J et al. · Archives of neurology · 2012

  6. 0.91

    Effect of CLU and PICALM polymorphisms on AD risk: A study from south India

    Shankarappa BM, Kota LN, Purushottam M et al. · Asian journal of psychiatry · 2017

  7. 0.90

    Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles

    Bennett DA, De Jager PL, Leurgans SE et al. · Neurology · 2009

  8. 0.90

    VEGF-A-related genetic variants protect against Alzheimer's disease

    Petrelis AM, Stathopoulou MG, Kafyra M et al. · Aging · 2022

  9. 0.89

    Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation

    Licastro F, Porcellini E, Caruso C et al. · Neurobiology of aging · 2007

  10. 0.89

    Polygenic risk of Alzheimer's disease in the Faroe Islands

    Johansen M, Joensen S, Restorff M et al. · European journal of neurology · 2022

  11. 0.89

    Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions

    Ebbert MTW, Ridge PG, Wilson AR et al. · Biological psychiatry · 2014

  12. 0.88

    Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer's disease by interacting with APOE epsilon4

    Zhang A, Zhao Q, Xu D et al. · Scientific reports · 2018

  13. 0.88

    A comprehensive genetic association study of Alzheimer disease in African Americans

    Logue MW, Schu M, Vardarajan BN et al. · Archives of neurology · 2011

  14. 0.87

    Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans

    Reitz C, Jun G, Naj A et al. · JAMA · 2013

  15. 0.87

    Non-coding variability at the APOE locus contributes to the Alzheimer's risk

    Zhou X, Chen Y, Mok KY et al. · Nature communications · 2019

  16. 0.86

    Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction

    Palmer ND, Kahali B, Kuppa A et al. · Human molecular genetics · 2021

  17. 0.85

    Alzheimer's disease genes and cognition in the nondemented general population

    Verhaaren BFJ, Vernooij MW, Koudstaal PJ et al. · Biological psychiatry · 2013

  18. 0.85

    Multi-omics Characterization of Epigenetic and Genetic Risk of Alzheimer Disease in Autopsied Brains from two Ethnic Groups

    Ma Y, Reyes-Dumeyer D, Piriz A et al. · medRxiv : the preprint server for health sciences · 2024

  19. 0.85

    PILRA polymorphism modifies the effect of APOE4 and GM17 on Alzheimer's disease risk

    Lopatko Lindman K, Jonsson C, Weidung B et al. · Scientific reports · 2022

  20. 0.84

    Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease

    Schott JM, Crutch SJ, Carrasquillo MM et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016

  21. 0.84

    New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors

    Gholami M, Ahmadi AA, Niaki MAA et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2026

  22. 0.84

    Genome-wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk

    Nazarian A, Loika Y, He L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022

  23. 0.83

    Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease

    Rajabli F, Benchek P, Tosto G et al. · Genome biology · 2025

  24. 0.83

    Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort

    Elias-Sonnenschein LS, Helisalmi S, Natunen T et al. · PloS one · 2013

  25. 0.83

    Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease

    Nho K, Kim S, Horgusluoglu E et al. · BMC medical genomics · 2017

  26. 0.82

    Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort

    Brookes KJ, McConnell G, Williams K et al. · Journal of Alzheimer's disease : JAD · 2018

  27. 0.82

    APOE*4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic Analyses

    Zeng Y, Cook N, Yang C et al. · medRxiv : the preprint server for health sciences · 2025

  28. 0.82

    Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes

    Jun G, Naj AC, Beecham GW et al. · Archives of neurology · 2010

  29. 0.82

    Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease

    Chaudhury S, Patel T, Barber IS et al. · Neurobiology of aging · 2018

  30. 0.82

    Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups

    Ma Y, Reyes-Dumeyer D, Piriz A et al. · Acta neuropathologica · 2024

  31. 0.82

    Genome-wide association study identifies APOE locus influencing plasma p-tau181 levels

    Huang YY, Yang YX, Wang HF et al. · Journal of human genetics · 2022

  32. 0.82

    Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory

    Barral S, Bird T, Goate A et al. · Neurology · 2012

  33. 0.81

    Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score

    Desikan RS, Fan CC, Wang Y et al. · PLoS medicine · 2017

  34. 0.81

    Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study

    Naj AC, Jun G, Reitz C et al. · JAMA neurology · 2014

  35. 0.81

    Performance Metrics for Selecting Single Nucleotide Polymorphisms in Late-onset Alzheimer's Disease

    Chen YC, Hsiao CJ, Jung CC et al. · Scientific reports · 2016

  36. 0.81

    Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis

    Patel M, Pottier C, Fan KH et al. · Human molecular genetics · 2025

  37. 0.80

    APOE and MS4A6A interact with GnRH signaling in Alzheimer's disease: Enrichment of epistatic effects

    Caceres A, Vargas JE, Gonzalez JR · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017

  38. 0.80

    Interpretable deep survival analysis of Alzheimer's disease via metabolic genetic variants

    Goo S, Lee S, Chae JW et al. · Bioinformatics (Oxford, England) · 2026

  39. 0.80

    APOE varepsilon4 allele and TOMM40-APOC1 variants jointly contribute to survival to older ages

    Kulminski AM, Jain-Washburn E, Philipp I et al. · Aging cell · 2022

  40. 0.80

    Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease

    Johansson A, Katzov H, Zetterberg H et al. · Human genetics · 2004

  41. 0.80

    Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease

    Chen Q, Aguirre L, Liang G et al. · Molecular neurodegeneration · 2024

  42. 0.79

    Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

    Belloy ME, Eger SJ, Le Guen Y et al. · Alzheimer's research & therapy · 2022

  43. 0.79

    Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE varepsilon4 negatives

    Najar J, van der Lee SJ, Joas E et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  44. 0.79

    Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel

    Meyer JM, Breitner JC · American journal of medical genetics · 1998

  45. 0.79

    A novel Alzheimer disease locus located near the gene encoding tau protein

    Jun G, Ibrahim-Verbaas CA, Vronskaya M et al. · Molecular psychiatry · 2016

  46. 0.79

    Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease risk

    Shigemizu D, Mitsumori R, Akiyama S et al. · Translational psychiatry · 2021

  47. 0.78

    Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study

    Han MR, Schellenberg GD, Wang LS · BMC neurology · 2010

  48. 0.78

    Multi-task learning identifies shared genetic risk for late-onset epilepsy and alzheimer's disease

    Fu M, Tran T, Pasaniuc B et al. · Scientific reports · 2025

  49. 0.78

    A novel approach to resilience and its links with education and Alzheimer's disease genetics

    Carrigan M, Bocancea DI, Vogel J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  50. 0.77

    Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer's disease pathogenesis

    Bracher-Smith M, Leonenko G, Baker E et al. · Neurobiology of aging · 2022

  51. 0.77

    Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD

    Carrasquillo MM, Khan QuA, Murray ME et al. · Neurology · 2014

  52. 0.77

    On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries

    Lee S, Hecker J, Hahn G et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  53. 0.77

    Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese Cohort

    Li WW, Wang Z, Fan DY et al. · Neuroscience bulletin · 2020

  54. 0.77

    GWAS on short tandem repeats identifies genetic mechanisms in Alzheimer's disease

    Gmelin D, Ohlei O, Aslam MM et al. · Nature communications · 2026

  55. 0.77

    Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta

    Kauwe JSK, Wang J, Mayo K et al. · Neurogenetics · 2009

  56. 0.76

    Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer's-type dementia

    Laureyssen C, Kucukali F, Van Dongen J et al. · Acta neuropathologica · 2024

  57. 0.76

    Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease

    Chouraki V, Reitz C, Maury F et al. · Journal of Alzheimer's disease : JAD · 2016

  58. 0.76

    Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach

    Martiskainen H, Helisalmi S, Viswanathan J et al. · Journal of Alzheimer's disease : JAD · 2015

  59. 0.76

    Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci

    Corder EH, Blennow K, Prince JA · Rejuvenation research · 2008

  60. 0.76

    DuAL-Net: A Dual-Network Approach for Alzheimer's Disease Risk Prediction Using APOE-Centered Regional Whole-Genome Sequencing Data

    Lee EH, Jo T · Computational and structural biotechnology journal · 2026

  61. 0.75

    A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction

    Zhang C, Hu R, Zhang G et al. · Journal of molecular neuroscience : MN · 2019

  62. 0.75

    Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population

    Klimkowicz-Mrowiec A, Sado M, Dziubek A et al. · Neurologia i neurochirurgia polska · 2013

  63. 0.75

    Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study

    Ware EB, Faul JD, Mitchell CM et al. · BMC medical genomics · 2020

  64. 0.75

    The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's disease

    Huang J, Tao Q, Ang TFA et al. · Translational psychiatry · 2022

  65. 0.75

    Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    de Rojas I, Moreno-Grau S, Tesi N et al. · Nature communications · 2021

  66. 0.75

    Identification of novel quantitative traits-associated susceptibility loci for APOE epsilon 4 non-carriers of Alzheimer's disease

    Jiang S, Yang W, Qiu Y et al. · Current Alzheimer research · 2015

  67. 0.74

    Cognitively healthy centenarians are genetically protected against Alzheimer's disease

    Tesi N, van der Lee S, Hulsman M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  68. 0.74

    The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects

    Sabuncu MR, Buckner RL, Smoller JW et al. · Cerebral cortex (New York, N.Y. : 1991) · 2012

  69. 0.74

    Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease

    Stevenson-Hoare J, Heslegrave A, Leonenko G et al. · Brain : a journal of neurology · 2023

  70. 0.74

    Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease

    Beecham GW, Martin ER, Li YJ et al. · American journal of human genetics · 2009

  71. 0.74

    Genome-wide association study of Alzheimer's disease

    Kamboh MI, Demirci FY, Wang X et al. · Translational psychiatry · 2012

  72. 0.73

    Association of Alzheimer's disease GWAS loci with MRI markers of brain aging

    Chauhan G, Adams HHH, Bis JC et al. · Neurobiology of aging · 2015

  73. 0.73

    A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Abeta42

    Sleegers K, Bettens K, De Roeck A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015

  74. 0.73

    Cross-sectional study of plasma phosphorylated tau 217 in persons without dementia

    Saari TT, Palviainen T, Hiltunen M et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  75. 0.73

    APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers's disease

    Thomassen JQ, Leonard H, Ulms B et al. · Nature genetics · 2026

  76. 0.73

    Whole-genome sequencing analyses suggest novel genetic factors associated with Alzheimer's disease and a cumulative effects model for risk liability

    Kim JP, Cho M, Kim C et al. · Nature communications · 2025

  77. 0.73

    Gene-based rare allele analysis identified a risk gene of Alzheimer's disease

    Kim JH, Song P, Lim H et al. · PloS one · 2014

  78. 0.73

    Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development

    Liu C, Chyr J, Zhao W et al. · Frontiers in genetics · 2018

  79. 0.72

    Alzheimer's disease genetic risk: Top African American risk allele frequencies and genetic architecture among Mexican-, African-, and non-Hispanic White Americans

    Housini M, Zhou Z, Abdullah L et al. · Alzheimer's & dementia (New York, N. Y.) · 2025

  80. 0.72

    Genetic susceptibility for Alzheimer disease neuritic plaque pathology

    Shulman JM, Chen K, Keenan BT et al. · JAMA neurology · 2013

  81. 0.72

    Genome-wide association analysis of age-at-onset in Alzheimer's disease

    Kamboh MI, Barmada MM, Demirci FY et al. · Molecular psychiatry · 2012

  82. 0.71

    GenoRisk: A polygenic risk score for Alzheimer's disease

    Dickson SP, Hendrix SB, Brown BL et al. · Alzheimer's & dementia (New York, N. Y.) · 2021

  83. 0.71

    Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease

    Potkin SG, Guffanti G, Lakatos A et al. · PloS one · 2009

  84. 0.71

    Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease

    Cruchaga C, Kauwe JSK, Nowotny P et al. · Human molecular genetics · 2012

  85. 0.70

    LD-informed deep learning for Alzheimer's gene loci detection using WGS data

    Jo T, Bice P, Nho K et al. · medRxiv : the preprint server for health sciences · 2024

  86. 0.70

    Genome-wide analysis of genetic loci associated with Alzheimer disease

    Seshadri S, Fitzpatrick AL, Ikram MA et al. · JAMA · 2010

  87. 0.70

    Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome

    Jones EL, Mok K, Hanney M et al. · Neurobiology of aging · 2013

  88. 0.69

    HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework

    Varol E, Sotiras A, Davatzikos C · NeuroImage · 2017

  89. 0.69

    Interactive effects of telomere length and genetic variants on Alzheimer disease risk across multiple ancestral populations

    Khurshid Z, Tong T, Olayinka O et al. · Alzheimer's research & therapy · 2026

  90. 0.69

    Genetic architecture of plasma Alzheimer disease biomarkers

    Bradley J, Gorijala P, Schindler SE et al. · Human molecular genetics · 2023

  91. 0.69

    Multi-ancestry meta-analysis identifies genetic modifiers of age-at-onset of Alzheimer's disease at known and novel loci

    Blue EE, Broome J, Xue D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  92. 0.69

    Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype

    Thambisetty M, An Y, Nalls M et al. · Biological psychiatry · 2013

  93. 0.68

    Genome-wide association studies of TDP-43 proteinopathy and hippocampal sclerosis reveal shared genetic associations with APOE and TMEM106B

    Godrich D, Pasteris J, Martin ER et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  94. 0.68

    Structured sparse CCA for brain imaging genetics via graph OSCAR

    Du L, Huang H, Yan J et al. · BMC systems biology · 2016

  95. 0.67

    Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition

    Kim JP, Jung SH, Jang B et al. · Nature communications · 2025

  96. 0.67

    Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms

    Lin YF, Smith AV, Aspelund T et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019

  97. 0.67

    Genetic variation and neuroimaging measures in Alzheimer disease

    Biffi A, Anderson CD, Desikan RS et al. · Archives of neurology · 2010

  98. 0.66

    APOE stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers's disease

    Thomassen JQ, Hampton L, Ulms B et al. · medRxiv : the preprint server for health sciences · 2025

  99. 0.66

    Genome-Wide Association Study of Cerebral Microbleeds on MRI

    Li HQ, Cai WJ, Hou XH et al. · Neurotoxicity research · 2020

  100. 0.66

    Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer's disease

    Meng X, Li J, Zhang Q et al. · BMC genomics · 2020

  101. 0.65

    Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels

    Maxwell TJ, Corcoran C, Del-Aguila JL et al. · Alzheimer's research & therapy · 2018

  102. 0.64

    A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer's disease

    Squillario M, Abate G, Tomasi F et al. · Scientific reports · 2020

  103. 0.64

    Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease

    Hao X, Li C, Du L et al. · Scientific reports · 2017

  104. 0.63

    Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-beta Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients

    Laitera T, Paananen J, Helisalmi S et al. · Journal of Alzheimer's disease : JAD · 2017

  105. 0.63

    Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Lambert JC, Ibrahim-Verbaas CA, Harold D et al. · Nature genetics · 2013

  106. 0.63

    Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+)

    Makela M, Kaivola K, Valori M et al. · Neurology. Genetics · 2018

  107. 0.63

    LD-informed deep learning for Alzheimer's gene loci detection using WGS data

    Jo T, Bice P, Nho K et al. · Alzheimer's & dementia (New York, N. Y.) · 2025

  108. 0.63

    Long-Lived Individuals Show a Lower Burden of Variants Predisposing to Age-Related Diseases and a Higher Polygenic Longevity Score

    Torres GG, Dose J, Hasenbein TP et al. · International journal of molecular sciences · 2022

  109. 0.62

    Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS)

    Shi H, Belbin O, Medway C et al. · Neurobiology of aging · 2012

  110. 0.62

    Genetic variants in glutamate-, Abeta-, and tau-related pathways determine polygenic risk for Alzheimer's disease

    Lawingco T, Chaudhury S, Brookes KJ et al. · Neurobiology of aging · 2021

  111. 0.62

    The genetic architecture of postoperative delirium after major surgery and its relationship with nonpostoperative neurocognitive conditions: A genome-wide association study

    Armstrong RA, Yousefi P, Gibbison B et al. · PLoS medicine · 2026

  112. 0.62

    Multiple loci influencing hippocampal degeneration identified by genome scan

    Melville SA, Buros J, Parrado AR et al. · Annals of neurology · 2012

  113. 0.62

    Differential burden of rare protein truncating variants in Alzheimer's disease patients compared to centenarians

    Freudenberg-Hua Y, Li W, Abhyankar A et al. · Human molecular genetics · 2016

  114. 0.62

    Comparing Pathway-Informed Polygenic Risk Score Strategies: A multi-cohort evaluation of Amyloid-beta

    Zhang X, Goudey B, Laws SM et al. · medRxiv : the preprint server for health sciences · 2026

  115. 0.62

    ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies

    Dai DL, Tropea TF, Robinson JL et al. · Acta neuropathologica · 2020

  116. 0.62

    TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly

    Pomara N, Bruno D, Nierenberg JJ et al. · Neurochemical research · 2011

  117. 0.62

    Identifying novel genetic variants for brain amyloid deposition: a genome-wide association study in the Korean population

    Kim HR, Jung SH, Kim J et al. · Alzheimer's research & therapy · 2021

  118. 0.61

    Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers

    Fan KH, Feingold E, Rosenthal SL et al. · Journal of Alzheimer's disease : JAD · 2020

  119. 0.61

    GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

    Timsina J, Jiang C, McCartney DL et al. · Nature communications · 2026

  120. 0.61

    Predicting accumulation and age at onset of amyloid-beta from genetic risk and resilience for Alzheimer's disease

    O'Brien EK, Cox T, Fernandez S et al. · EBioMedicine · 2026

  121. 0.61

    Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO

    Puerta R, de Rojas I, Garcia-Gonzalez P et al. · Functional & integrative genomics · 2025

  122. 0.61

    Genome-wide association study of Alzheimer's disease with psychotic symptoms

    Hollingworth P, Sweet R, Sims R et al. · Molecular psychiatry · 2012

  123. 0.60

    Exploratory analysis of seven Alzheimer's disease genes: disease progression

    Ruiz A, Hernandez I, Ronsende-Roca M et al. · Neurobiology of aging · 2013

  124. 0.60

    African ancestry GWAS of dementia in a large military cohort identifies significant risk loci

    Sherva R, Zhang R, Sahelijo N et al. · Molecular psychiatry · 2023

  125. 0.60

    Polygenic hazard score models for the prediction of Alzheimer's free survival using the lasso for Cox's proportional hazards model

    Hahn G, Prokopenko D, Hecker J et al. · Genetic epidemiology · 2025

  126. 0.59

    Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions

    Reiman EM, Chen K, Caselli RJ et al. · NeuroImage · 2008

  127. 0.59

    Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

    Hong S, Prokopenko D, Dobricic V et al. · Translational psychiatry · 2020

  128. 0.59

    Polygenic Risk Score for Alzheimer's Disease Is Associated With Ch4 Volume in Normal Subjects

    Wang T, Han Z, Yang Y et al. · Frontiers in genetics · 2019

  129. 0.58

    Genetic drivers of progression in Alzheimer's disease are distinct from disease risk

    Cohen CE, Fernandez S, Yaman U et al. · Alzheimer's research & therapy · 2026

  130. 0.58

    Benchmarking Alzheimer's disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies

    Bellou E, Kim W, Leonenko G et al. · Alzheimer's research & therapy · 2025

  131. 0.58

    A Genetic Validation of the Neurodegeneration Biomarkers Tau-A and Tau-C - A Mendelian Randomization Study

    Axelsen TM, Bager C, Bihlet A et al. · The journal of prevention of Alzheimer's disease · 2023

  132. 0.58

    Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration

    Tan CH, Bonham LW, Fan CC et al. · Brain : a journal of neurology · 2019

  133. 0.58

    Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

    DeMichele-Sweet MAA, Klei L, Creese B et al. · Molecular psychiatry · 2021

  134. 0.57

    Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome

    Andrews SJ, Fulton-Howard B, O'Reilly P et al. · Annals of neurology · 2021

  135. 0.57

    Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer

    Pathak GA, Zhou Z, Silzer TK et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020

  136. 0.57

    Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90

    Heath L, Earls JC, Magis AT et al. · Scientific reports · 2022

  137. 0.57

    Association of whole-person eigen-polygenic risk scores with Alzheimer's disease

    Kharaghani A, Tio ES, Milic M et al. · Human molecular genetics · 2024

  138. 0.56

    GBA and APOE epsilon4 associate with sporadic dementia with Lewy bodies in European genome wide association study

    Rongve A, Witoelar A, Ruiz A et al. · Scientific reports · 2019

  139. 0.56

    Data mining of high density genomic variant data for prediction of Alzheimer's disease risk

    Briones N, Dinu V · BMC medical genetics · 2012

  140. 0.56

    Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-beta Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease

    Darst BF, Koscik RL, Racine AM et al. · Journal of Alzheimer's disease : JAD · 2017

  141. 0.55

    Sex differences in the genetic predictors of Alzheimer's pathology

    Dumitrescu L, Barnes LL, Thambisetty M et al. · Brain : a journal of neurology · 2019

  142. 0.55

    Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses

    Yashin AI, Fang F, Kovtun M et al. · Experimental gerontology · 2018

  143. 0.53

    Detecting genetic associations with brain imaging phenotypes in Alzheimer's disease via a novel structured KCCA approach

    Wang L, Kong W, Wang S · Journal of bioinformatics and computational biology · 2021

  144. 0.53

    Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers

    Alexopoulos P, Guo LH, Kratzer M et al. · Dementia and geriatric cognitive disorders · 2011

  145. 0.53

    Towards compendia of negative genetic association studies: an example for Alzheimer disease

    Blomqvist MEL, Reynolds C, Katzov H et al. · Human genetics · 2006

  146. 0.53

    Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium

    Debette S, Ibrahim Verbaas CA, Bressler J et al. · Biological psychiatry · 2015

  147. 0.53

    Patient stratification by genetic risk in Alzheimer's disease is only effective in the presence of phenotypic heterogeneity

    Euesden J, Ali M, Robins C et al. · PloS one · 2025

  148. 0.52

    Imaging-genetics-based dementia risk prediction using deep survival neural networks in the Rotterdam Study

    Yu J, Rosbergen MT, Wolters FJ et al. · Scientific reports · 2026

  149. 0.52

    Association Analysis Between Ischemic Stroke Risk Single Nucleotide Polymorphisms and Alzheimer's Disease

    Dong W, Wang W, Li M · Bioengineering (Basel, Switzerland) · 2025

  150. 0.51

    Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    Lambert JC, Heath S, Even G et al. · Nature genetics · 2009

  151. 0.50

    Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949)

    Davies G, Armstrong N, Bis JC et al. · Molecular psychiatry · 2015

  152. 0.50

    Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci

    Holton P, Ryten M, Nalls M et al. · Annals of human genetics · 2013

  153. 0.50

    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

    Ferrari R, Wang Y, Vandrovcova J et al. · Journal of neurology, neurosurgery, and psychiatry · 2017

  154. 0.50

    Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores

    Hermes S, Cady J, Armentrout S et al. · Journal of Alzheimer's disease : JAD · 2024

04metabolism · protein88편

  1. 0.94

    Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease

    Kumar NT, Liestol K, Loberg EM et al. · Virchows Archiv : an international journal of pathology · 2015

  2. 0.93

    ApoE Gene Polymorphism and Clinical, Biochemical, and Sociodemographic Characteristics of Alzheimer's Disease Patients From Northern and Southern Regions of Kazakhstan

    Zholdasbekova G, Kaiyrlykyzy A, Kassenova A et al. · International journal of geriatric psychiatry · 2024

  3. 0.93

    Association between apolipoprotein E gene polymorphisms and serum lipid indicators and Alzheimer's disease risk

    Chen H, Zhang H, Yang M et al. · Journal of Alzheimer's disease : JAD · 2026

  4. 0.93

    Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction

    Sutovsky S, Petrovic R, Fischerova M et al. · Journal of Alzheimer's disease : JAD · 2020

  5. 0.92

    The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type

    Regland B, Blennow K, Germgard T et al. · Dementia and geriatric cognitive disorders · 1999

  6. 0.92

    Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease

    Raygani AV, Rahimi Z, Kharazi H et al. · Neuroscience letters · 2006

  7. 0.92

    CYP46A1 and the APOEepsilon4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease

    Li L, Zeng F, Liu YH et al. · Molecular neurobiology · 2018

  8. 0.91

    Epistatic interaction of apolipoprotein E and lipolysis-stimulated lipoprotein receptor genetic variants is associated with Alzheimer's disease

    Xie T, Akbar S, Stathopoulou MG et al. · Neurobiology of aging · 2018

  9. 0.91

    Relationship Between Genetic Variants of ACAT1 and APOE with the Susceptibility to Dementia (SADEM Study)

    Alavez-Rubio JS, Martinez-Rodriguez N, Escobedo-de-la-Pena J et al. · Molecular neurobiology · 2021

  10. 0.91

    Interleukin-8-251T > A, Interleukin-1alpha-889C > T and Apolipoprotein E polymorphisms in Alzheimer's disease

    Vendramini AA, de Labio RW, Rasmussen LT et al. · Genetics and molecular biology · 2011

  11. 0.90

    Role of genes GSTM1, GSTT1, and MnSOD in the development of late-onset Alzheimer disease and their relationship with APOE*4

    de Mendonca E, Salazar Alcala E, Fernandez-Mestre M · Neurologia (Barcelona, Spain) · 2016

  12. 0.90

    Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele

    Rodriguez E, Mateo I, Infante J et al. · Journal of neurology · 2006

  13. 0.89

    Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary

    Kovacs KA, Pamer Z, Kovacs A et al. · Ideggyogyaszati szemle · 2007

  14. 0.88

    Inter- and intra-chromosomal modulators of the APOE varepsilon2 and varepsilon4 effects on the Alzheimer's disease risk

    Nazarian A, Philipp I, Culminskaya I et al. · GeroScience · 2023

  15. 0.88

    Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases

    Tisato V, Zuliani G, Vigliano M et al. · PloS one · 2018

  16. 0.88

    Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease

    Dai J, Johnson ECB, Dammer EB et al. · Frontiers in molecular neuroscience · 2018

  17. 0.87

    The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease

    Dupuy AM, Mas E, Ritchie K et al. · Gerontology · 2001

  18. 0.86

    Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender

    Bullido MJ, Guallar-Castillon P, Artiga MJ et al. · Neuroscience letters · 2000

  19. 0.86

    Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease

    Cheng D, Huang R, Lanham IS et al. · Journal of medical genetics · 2005

  20. 0.86

    Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease

    Thal DR, Papassotiropoulos A, Saido TC et al. · Acta neuropathologica · 2010

  21. 0.85

    Positive association of a Sirt1 variant and parameters of oxidative stress on Alzheimer's disease

    Camporez D, Belcavello L, Almeida JFF et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021

  22. 0.83

    The apolipoprotein E epsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase

    Darreh-Shori T, Modiri N, Blennow K et al. · Neurobiology of aging · 2011

  23. 0.83

    Differential associations of APOE and TREM2 variants with glial fibrillary acidic protein and neurofilament light in plasma of UK Biobank participants support distinct disease mechanisms

    Freudenberg-Hua Y, Giliberto L, d'Abramo C et al. · Molecular psychiatry · 2025

  24. 0.83

    Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk

    Vazquez-Higuera JL, Mateo I, Sanchez-Juan P et al. · Dementia and geriatric cognitive disorders · 2009

  25. 0.82

    rs140926439 Variant in the Fibronectin FN1 Gene Lowers Risk of Alzheimer Disease in APOEepsilon4 Carriers in the UK Biobank Cohort

    Lehrer S, Rheinstein PH · Alzheimer disease and associated disorders · 2025

  26. 0.82

    Apolipoprotein epsilon4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease

    Darreh-Shori T, Siawesh M, Mousavi M et al. · Journal of Alzheimer's disease : JAD · 2012

  27. 0.82

    Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women

    Fontalba A, Gutierrez O, Llorca J et al. · Dementia and geriatric cognitive disorders · 2008

  28. 0.81

    Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease

    Jasiecki J, Limon-Sztencel A, Zuk M et al. · Scientific reports · 2019

  29. 0.81

    Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function

    Liu Y, Gu X, Li Y et al. · Nature medicine · 2025

  30. 0.81

    Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism

    Seripa D, Matera MG, D'Andrea RP et al. · Neurology · 2004

  31. 0.80

    SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele

    Spell C, Kolsch H, Lutjohann D et al. · Dementia and geriatric cognitive disorders · 2004

  32. 0.79

    Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene

    Kamboh MI, Ferrell RE, DeKosky ST · Neuroscience letters · 1998

  33. 0.78

    ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy

    Montanola A, de Retana SF, Lopez-Rueda A et al. · Neuromolecular medicine · 2016

  34. 0.78

    A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease

    Papassotiropoulos A, Wollmer MA, Tsolaki M et al. · The Journal of clinical psychiatry · 2005

  35. 0.78

    Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation

    Crespo AC, Silva B, Marques L et al. · Neurobiology of aging · 2014

  36. 0.78

    APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein

    Chalmers K, Wilcock GK, Love S · Neuropathology and applied neurobiology · 2003

  37. 0.77

    Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease

    Glockner F, Meske V, Ohm TG · Neuroscience · 2002

  38. 0.77

    The APOE Gene is Differentially Methylated in Alzheimer's Disease

    Foraker J, Millard SP, Leong L et al. · Journal of Alzheimer's disease : JAD · 2015

  39. 0.76

    Discovery of a Missense Mutation (Q222K) of the APOE Gene from the Australian Imaging, Biomarker and Lifestyle Study

    Roberts BR, Laffoon SB, Roberts AM et al. · Journal of Alzheimer's disease reports · 2023

  40. 0.75

    Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE varepsilon2 for Alzheimer's disease

    Jun GR, You Y, Zhu C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022

  41. 0.75

    APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer's disease

    Brookhouser N, Raman S, Frisch C et al. · Molecular psychiatry · 2021

  42. 0.75

    Association Studies of Specific Cholesterol Related Genes (APOE, LPL, and CETP) with Lipid Profile and Memory Function: A Correlative Study Among Rural and Tribal Population of Dharmapuri District, India

    Periyasamy S, Sathya M, Karthick C et al. · Journal of Alzheimer's disease : JAD · 2017

  43. 0.74

    Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

    Minta K, Brinkmalm G, Janelidze S et al. · Alzheimer's research & therapy · 2020

  44. 0.74

    CD36 gene polymorphism is associated with Alzheimer's disease

    Sery O, Janoutova J, Ewerlingova L et al. · Biochimie · 2017

  45. 0.73

    The Neurobiology and Age-Related Prevalence of the epsilon4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts

    Heffernan AL, Chidgey C, Peng P et al. · Journal of molecular neuroscience : MN · 2016

  46. 0.71

    Rapidly progressive Alzheimer's disease features distinct structures of amyloid-beta

    Cohen ML, Kim C, Haldiman T et al. · Brain : a journal of neurology · 2015

  47. 0.71

    Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides

    Simon R, Girod M, Fonbonne C et al. · Molecular & cellular proteomics : MCP · 2012

  48. 0.70

    Apolipoprotein E2 Expression Alters Endosomal Pathways in a Mouse Model With Increased Brain Exosome Levels During Aging

    Peng KY, Liemisa B, Pasato J et al. · Traffic (Copenhagen, Denmark) · 2024

  49. 0.69

    Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease

    Bai F, Yuan Y, Shi Y et al. · Oncotarget · 2016

  50. 0.69

    Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging

    Jagust WJ, Landau SM · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012

  51. 0.69

    Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease

    Flex A, Giovannini S, Biscetti F et al. · Neuro-degenerative diseases · 2014

  52. 0.68

    Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia

    Helbecque N, Cottel D, Amouyel P · Neurobiology of aging · 2009

  53. 0.67

    Effects of NR1H3 genetic variation on the expression of liver X receptor alpha and the progression of Alzheimer's disease

    Natunen T, Martiskainen H, Sarajarvi T et al. · PloS one · 2013

  54. 0.66

    The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism

    Corder EH, Ghebremedhin E, Taylor MG et al. · Annals of the New York Academy of Sciences · 2004

  55. 0.66

    Alzheimer's Disease: Causal Effect between Obesity and APOE Gene Polymorphisms

    Zhao T, Zhong T, Zhang M et al. · International journal of molecular sciences · 2023

  56. 0.64

    Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk

    Rodriguez-Rodriguez E, Mateo I, Infante J et al. · Brain research · 2009

  57. 0.64

    Microbiome alterations are associated with apolipoprotein E mutation in Octodon degus and humans with Alzheimer's disease

    Zampieri G, Cabrol L, Urra C et al. · iScience · 2024

  58. 0.62

    Sharing pathogenetic mechanisms between acute myocardial infarction and Alzheimer's disease as shown by partially overlapping of gene variant profiles

    Licastro F, Chiappelli M, Caldarera CM et al. · Journal of Alzheimer's disease : JAD · 2011

  59. 0.60

    Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults

    Yuan L, Liu J, Dong L et al. · Nutrients · 2015

  60. 0.59

    Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo

    Darreh-Shori T, Forsberg A, Modiri N et al. · Neurobiology of aging · 2011

  61. 0.58

    The APOE gene cluster responds to air pollution factors in mice with coordinated expression of genes that differs by age in humans

    Haghani A, Thorwald M, Morgan TE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021

  62. 0.58

    The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy

    Rebeck GW, Cho HS, Grabowski TJ et al. · Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2001

  63. 0.58

    Chronic exposure to chlorpyrifos triggered body weight increase and memory impairment depending on human apoE polymorphisms in a targeted replacement mouse model

    Peris-Sampedro F, Basaure P, Reverte I et al. · Physiology & behavior · 2015

  64. 0.57

    Apolipoprotein E and beta A4-amyloid: signals and effects

    Ohm TG, Hamker U, Cedazo-Minguez A et al. · Biochemical Society symposium · 2001

  65. 0.57

    No association of genetic variants of liver X receptor-beta with Alzheimer's disease risk

    Rodriguez-Rodriguez E, Llorca J, Mateo I et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2008

  66. 0.57

    Quantitative and Kinetic Proteomics Reveal ApoE Isoform-dependent Proteostasis Adaptations in Mouse Brain

    Zuniga NR, Earls NE, Denos AEA et al. · PLoS computational biology · 2024

  67. 0.57

    CCR5 deficiency: Decreased neuronal resilience to oxidative stress and increased risk of vascular dementia

    Tournier BB, Sorce S, Marteyn A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  68. 0.56

    Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease

    Maloney B, Ge YW, Alley GM et al. · Journal of neurochemistry · 2007

  69. 0.56

    Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer's disease patients

    Prendecki M, Florczak-Wyspianska J, Kowalska M et al. · Oncotarget · 2018

  70. 0.56

    Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients

    Gabriel AJ, Almeida MR, Ribeiro MH et al. · Neuroscience letters · 2017

  71. 0.56

    Apolipoprotein E polymorphism and dendritic shape in hippocampal interneurons

    Schonheit B, Glockner F, Ohm TG · Neurobiology of aging · 2007

  72. 0.54

    Chromosomal DNA damage in APOE varepsilon4 carriers and noncarriers does not appear to be different

    Chua A, Thomas P, Clifton P et al. · Environmental and molecular mutagenesis · 2015

  73. 0.54

    Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels

    Riddell DR, Zhou H, Atchison K et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008

  74. 0.53

    Analysis of Salivary Microbiome in Patients with Alzheimer's Disease

    Liu XX, Jiao B, Liao XX et al. · Journal of Alzheimer's disease : JAD · 2019

  75. 0.53

    Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?

    Corbo RM, Scacchi R · Annals of human genetics · 1999

  76. 0.53

    The effect of apolipoprotein E polymorphism on serum metabolome - a population-based 10-year follow-up study

    Karjalainen JP, Mononen N, Hutri-Kahonen N et al. · Scientific reports · 2019

  77. 0.53

    Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease

    Lee EG, Tulloch J, Chen S et al. · PloS one · 2020

  78. 0.52

    A differential association of Apolipoprotein E isoforms with the amyloid-beta oligomer in solution

    Petrlova J, Hong HS, Bricarello DA et al. · Proteins · 2011

  79. 0.52

    The role of APOE polymorphisms in late-onset dementias

    Corder EH, Lannfelt L, Bogdanovic N et al. · Cellular and molecular life sciences : CMLS · 1998

  80. 0.52

    Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis

    Winkler K, Scharnagl H, Tisljar U et al. · Journal of lipid research · 1999

  81. 0.52

    The influence of APOE(epsilon4) on the pTau interactome in sporadic Alzheimer's disease

    Thierry M, Ponce J, Marta-Ariza M et al. · Acta neuropathologica · 2024

  82. 0.52

    Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer's disease

    Caberlotto L, Marchetti L, Lauria M et al. · Scientific reports · 2016

  83. 0.51

    Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein

    Irizarry MC, Deng A, Lleo A et al. · Journal of neurochemistry · 2004

  84. 0.51

    No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease

    Micheli D, Bonvicini C, Rocchi A et al. · Journal of Alzheimer's disease : JAD · 2006

  85. 0.51

    Decreased plasma C-reactive protein levels in APOE epsilon4 allele carriers

    Martiskainen H, Takalo M, Solomon A et al. · Annals of clinical and translational neurology · 2018

  86. 0.51

    Metabolic Overlap between Alzheimer's Disease and Metabolic Syndrome Identifies the PVRL2 Gene as a New Modulator of Diabetic Dyslipidemia

    Guardiola M, Muntane G, Martinez I et al. · International journal of molecular sciences · 2023

  87. 0.51

    APOE4 triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly

    Chen F, Chen Y, Feng S et al. · Cellular and molecular life sciences : CMLS · 2025

  88. 0.50

    Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner

    Vincent B, Smith JD · The European journal of neuroscience · 2001

05promoter · region81편

  1. 0.95

    The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism

    Town T, Paris D, Fallin D et al. · Neuroscience letters · 1998

  2. 0.95

    Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease

    Bahia VS, Kok F, Marie SN et al. · Alzheimer disease and associated disorders · 2008

  3. 0.95

    The complex interaction between APOE promoter and AD: an Italian case-control study

    Bizzarro A, Seripa D, Acciarri A et al. · European journal of human genetics : EJHG · 2009

  4. 0.95

    Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease

    Bratosiewicz-Wasik J, Liberski PP, Peplonska B et al. · Neuroscience letters · 2018

  5. 0.95

    An APOE haplotype associated with decreased epsilon4 expression increases the risk of late onset Alzheimer's disease

    Lescai F, Chiamenti AM, Codemo A et al. · Journal of Alzheimer's disease : JAD · 2011

  6. 0.95

    Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients

    Parra-Bonilla G, Arboleda G, Yunis J et al. · Neuroscience letters · 2003

  7. 0.95

    A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease

    Lambert JC, Pasquier F, Cottel D et al. · Human molecular genetics · 1998

  8. 0.95

    APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE epsilon4 on Alzheimer's Disease Risk in a Multiracial Sample 이 논문

    Choi KY, Lee JJ, Gunasekaran TI et al. · Journal of clinical medicine · 2019

  9. 0.94

    Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease

    Nicodemus KK, Stenger JE, Schmechel DE et al. · Neurogenetics · 2004

  10. 0.94

    Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene

    Artiga MJ, Bullido MJ, Frank A et al. · Human molecular genetics · 1998

  11. 0.94

    Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease

    Parker GR, Cathcart HM, Huang R et al. · Psychiatric genetics · 2005

  12. 0.94

    The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease

    Laws SM, Taddei K, Martins G et al. · Neuroreport · 1999

  13. 0.94

    APOE promoter polymorphisms and dementia in the elderly

    Lambert JC, Berr C, Cottel D et al. · Neuroscience letters · 2004

  14. 0.94

    Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease

    Wang JC, Kwon JM, Shah P et al. · Neurology · 2000

  15. 0.93

    Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE

    Song YQ, Rogaeva E, Premkumar S et al. · Neuroscience letters · 1998

  16. 0.93

    Association between Alzheimer disease and the -491T allele of regulatory region polymorphism of Apolipoprotein E in a Tunisian population

    Achouri-Rassas A, Hadj Fredj S, Mrabet Khiari H et al. · Neurochemical research · 2014

  17. 0.93

    The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease

    Ahmed AR, MacGowan SH, Culpan D et al. · Neuroscience letters · 1999

  18. 0.93

    The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease

    Alvarez-Arcaya A, Combarros O, Llorca J et al. · Neuroscience letters · 2001

  19. 0.93

    ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population

    Juhasz A, Palotas A, Janka Z et al. · Neurochemical research · 2005

  20. 0.93

    Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease

    Lambert JC, Berr C, Pasquier F et al. · Human molecular genetics · 1998

  21. 0.93

    Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease

    Halimi G, Duplan L, Bideau C et al. · Neuroreport · 2000

  22. 0.93

    ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain

    Myllykangas L, Polvikoski T, Reunanen K et al. · American journal of medical genetics · 2002

  23. 0.93

    Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population

    Yang JD, Feng GY, Zhang J et al. · Neuroscience letters · 2003

  24. 0.93

    Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population

    Toji H, Maruyama H, Sasaki K et al. · Neuroscience letters · 1999

  25. 0.92

    Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease

    Belbin O, Dunn JL, Ling Y et al. · Human molecular genetics · 2007

  26. 0.92

    The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset

    Beyer K, Lao JI, Gomez M et al. · Neuroscience letters · 2002

  27. 0.92

    The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms

    Limon-Sztencel A, Lipska-Zietkiewicz BS, Chmara M et al. · Alzheimer's research & therapy · 2016

  28. 0.92

    APOE and AbetaPP gene variation in cortical and cerebrovascular amyloid-beta pathology and Alzheimer's disease: a population-based analysis

    Peuralinna T, Tanskanen M, Makela M et al. · Journal of Alzheimer's disease : JAD · 2011

  29. 0.92

    Contribution of APOE promoter polymorphisms to Alzheimer's disease risk

    Lambert JC, Araria-Goumidi L, Myllykangas L et al. · Neurology · 2002

  30. 0.92

    Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals

    Helisalmi S, Hiltunen M, Valonen P et al. · Journal of neurology · 1999

  31. 0.92

    Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study

    Roks G, Cruts M, Houwing-Duistermaat JJ et al. · American journal of medical genetics · 2002

  32. 0.92

    The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia

    Trebunova M, Slaba E, Habalova V et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2009

  33. 0.91

    Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease

    Rebeck GW, Cheung BS, Growdon WB et al. · Neuroscience letters · 1999

  34. 0.91

    Identification of a protective allele against Alzheimer disease in the APOE gene promoter

    Beyer K, Lao JI, Gomez M et al. · Neuroreport · 2002

  35. 0.90

    APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population

    Zurutuza L, Verpillat P, Raux G et al. · European journal of human genetics : EJHG · 2000

  36. 0.90

    Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns

    Saarela MS, Lehtimaki T, Rinne JO et al. · Neuroscience letters · 2004

  37. 0.90

    A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia

    Bullido MJ, Artiga MJ, Recuero M et al. · Nature genetics · 1998

  38. 0.90

    APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals

    Tycko B, Lee JH, Ciappa A et al. · Archives of neurology · 2004

  39. 0.90

    The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease

    Roks G, Cruts M, Bullido MJ et al. · Neuroscience letters · 1998

  40. 0.90

    Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease

    Chen L, Baum L, Ng HK et al. · Neuroscience letters · 1999

  41. 0.90

    Association study of apolipoprotein E promoter polymorphism (-427 T/C) and Alzheimer's disease in a Tunisian population

    Achouri-Rassas A, Ben Ali N, Fray S et al. · Revue neurologique · 2016

  42. 0.90

    MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males

    Reynolds WF, Hiltunen M, Pirskanen M et al. · Neurology · 2000

  43. 0.89

    APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease

    Chalmers KA, Culpan D, Kehoe PG et al. · Neuroreport · 2004

  44. 0.89

    No evidence of association between apolipoprotein E gene regulatory region polymorphism and Alzheimer's disease in Japanese

    Kimura M, Matsushita S, Arai H et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2000

  45. 0.88

    Genetic and regulatory architecture of Alzheimer's disease in the APOE region

    Kulminski AM, Shu L, Loika Y et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2020

  46. 0.88

    APOE region molecular signatures of Alzheimer's disease across races/ethnicities

    Kulminski AM, Shu L, Loika Y et al. · Neurobiology of aging · 2020

  47. 0.87

    Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease

    Yamagata H, Chen Y, Akatsu H et al. · Biochemical and biophysical research communications · 2004

  48. 0.86

    Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele

    Pahnke J, Walker LC, Schroeder E et al. · Acta neuropathologica · 2003

  49. 0.86

    The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers

    Matsubara-Tsutsui M, Yamagata H, Morishima A et al. · Internal medicine (Tokyo, Japan) · 2002

  50. 0.86

    Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions

    Maloney B, Ge YW, Petersen RC et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2010

  51. 0.86

    Membership in genetic groups predicts Alzheimer disease

    Corder EH, Huang R, Cathcart HM et al. · Rejuvenation research · 2006

  52. 0.86

    Cluster analysis of risk factor genetic polymorphisms in Alzheimer's disease

    Randall CN, Strasburger D, Prozonic J et al. · Neurochemical research · 2009

  53. 0.85

    The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients

    Valenza A, Bizzarro A, Marra C et al. · Neuroscience letters · 2010

  54. 0.83

    Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population

    Li K, Dai D, Yao L et al. · Neuroscience letters · 2008

  55. 0.83

    Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern

    Scacchi R, Gambina G, Martini MC et al. · Dementia and geriatric cognitive disorders · 2001

  56. 0.82

    Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease

    Gnjec A, D'Costa KJ, Laws SM et al. · Journal of neuroinflammation · 2008

  57. 0.82

    The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE epsilon 4 carriers

    Wang M, Jia J · Neuroscience letters · 2010

  58. 0.82

    Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?

    Thome J, Gewirtz JC, Sakai N et al. · Neuroscience letters · 1999

  59. 0.81

    Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease

    Edland SD · Journal of molecular neuroscience : MN · 2004

  60. 0.80

    Distortion of allelic expression of apolipoprotein E in Alzheimer's disease

    Lambert JC, Perez-Tur J, Dupire MJ et al. · Human molecular genetics · 1997

  61. 0.77

    No synergistic effect between -850 tumor necrosis factor-alpha promoter polymorphism and apolipoprotein E epsilon 4 allele in Alzheimer's disease

    Infante J, Llorca J, Berciano J et al. · Neuroscience letters · 2002

  62. 0.76

    Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E

    Laws SM, Hone E, Taddei K et al. · Molecular psychiatry · 2002

  63. 0.76

    Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes

    Bray NJ, Jehu L, Moskvina V et al. · Human molecular genetics · 2004

  64. 0.75

    Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease

    Ramos EM, Lin MT, Larson EB et al. · Archives of neurology · 2006

  65. 0.74

    Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity

    Campillos M, Lamas JR, Garcia MA et al. · Nucleic acids research · 2003

  66. 0.71

    The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease

    Lambert JC, Coyle N, Lendon C · Journal of medical genetics · 2004

  67. 0.70

    Association of genetic variants of ABCA1 with Alzheimer's disease risk

    Rodriguez-Rodriguez E, Mateo I, Llorca J et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2007

  68. 0.70

    Association of IL10 promoter polymorphism in Italian Alzheimer's disease

    Bagnoli S, Cellini E, Tedde A et al. · Neuroscience letters · 2007

  69. 0.69

    Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: an association study

    Hellman NE, Grant EA, Goate AM · Annals of neurology · 1998

  70. 0.67

    Cytokine polymorphisms and Alzheimer disease: possible associations

    Ribizzi G, Fiordoro S, Barocci S et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2010

  71. 0.66

    Association of a NOS1 promoter repeat with Alzheimer's disease

    Galimberti D, Scarpini E, Venturelli E et al. · Neurobiology of aging · 2008

  72. 0.66

    APOE genotype-function relationship: evidence of -491 A/T promoter polymorphism modifying transcription control but not type 2 diabetes risk

    Geng H, Law PPY, Ng MCY et al. · PloS one · 2011

  73. 0.66

    Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study

    Quan W, Yasuda M, Hashimoto M et al. · Journal of the neurological sciences · 2006

  74. 0.65

    Genetic variation of the APOE promoter and outcome after head injury

    Lendon CL, Harris JM, Pritchard AL et al. · Neurology · 2003

  75. 0.64

    S100B gene polymorphisms are associated with the S100B level and Alzheimer's disease risk by altering the miRNA binding capacity

    Wang J, Zhou Y, Yang Y et al. · Aging · 2021

  76. 0.62

    No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease

    Combarros O, Infante J, Llorca J et al. · Neuroscience letters · 2004

  77. 0.55

    Association of OGG1 and DLST promoter methylation with Alzheimer's disease in Xinjiang population

    Chen W, Zhou X, Duan Y et al. · Experimental and therapeutic medicine · 2018

  78. 0.54

    Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain

    Deniz-Naranjo MC, Munoz-Fernandez C, Alemany-Rodriguez MJ et al. · European journal of neurology · 2008

  79. 0.53

    Association study of Notch 4 polymorphisms with Alzheimer's disease

    Lambert JC, Mann D, Harris J et al. · Journal of neurology, neurosurgery, and psychiatry · 2004

  80. 0.53

    Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease

    Capurso C, Solfrizzi V, Colacicco AM et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2010

  81. 0.53

    A functional polymorphism in the HMGCR promoter affects transcriptional activity but not the risk for Alzheimer disease in Swedish populations

    Keller L, Murphy C, Wang HX et al. · Brain research · 2010

06haplotype · genes78편

  1. 0.94

    A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease

    Coon KD, Myers AJ, Craig DW et al. · The Journal of clinical psychiatry · 2007

  2. 0.94

    Potential genetic biomarkers in the early diagnosis of Alzheimer disease: APOE and BIN1

    Kaya G, Gunduz E, Acar M et al. · Turkish journal of medical sciences · 2015

  3. 0.93

    Association of Alzheimer's Disease with Genetic Variants of Apolipoprotein E, Clusterin, TNF-alpha, and IL-6 Among Elderly Saudis

    Abdi S, Alghamdi AA, AlGhunaim NNA et al. · Current pharmaceutical biotechnology · 2022

  4. 0.93

    Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls

    Perry RT, Collins JS, Harrell LE et al. · American journal of medical genetics · 2001

  5. 0.91

    Haplotype analysis of APOE intragenic SNPs

    Babenko VN, Afonnikov DA, Ignatieva EV et al. · BMC neuroscience · 2018

  6. 0.91

    Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease

    Lilius L, Froelich Fabre S, Basun H et al. · Neuroscience letters · 1999

  7. 0.91

    APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease

    Velez JI, Lopera F, Sepulveda-Falla D et al. · Molecular psychiatry · 2016

  8. 0.91

    Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease

    Styczynska M, Religa D, Pfeffer A et al. · Neuroscience letters · 2003

  9. 0.90

    The synergistic risk effect of apolipoprotein epsilon4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease

    de Bem CMBE, Pezzi JC, Borba EM et al. · Molecular biology reports · 2016

  10. 0.90

    Haplotype architecture of the Alzheimer's risk in the APOE region via co-skewness

    Kulminski AM, Philipp I, Loika Y et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2020

  11. 0.89

    A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases

    Soyal SM, Kwik M, Kalev O et al. · Molecular genetics & genomic medicine · 2020

  12. 0.88

    GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers

    Ramirez-Lorca R, Boada M, Saez ME et al. · The journal of nutrition, health & aging · 2009

  13. 0.88

    Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes

    Golanska E, Hulas-Bigoszewska K, Sieruta M et al. · Journal of Alzheimer's disease : JAD · 2009

  14. 0.88

    The effects and interactions of APOE and APH-1A polymorphisms in Alzheimer disease

    Acar Cinleti B, Yardimci N, Ayturk Z et al. · Turkish journal of medical sciences · 2015

  15. 0.87

    Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4 RECODE

    Kim KW, Suh YJ, Park WY et al. · Neuroscience letters · 2004

  16. 0.87

    Mitochondrial DNA and Alzheimer's disease: a first case-control study of the Tunisian population

    Ben Salem N, Boussetta S, de Rojas I et al. · Molecular biology reports · 2022

  17. 0.86

    Genetic study of Sardinian patients with Alzheimer's disease

    Piscopo P, Manfredi A, Malvezzi-Campeggi L et al. · Neuroscience letters · 2006

  18. 0.86

    Synergistic Effect between the APOE epsilon4 Allele with Genetic Variants of GSK3B and MAPT: Differential Profile between Refractory Epilepsy and Alzheimer Disease

    Toral-Rios D, Pichardo-Rojas P, Ruiz-Sanchez E et al. · International journal of molecular sciences · 2024

  19. 0.86

    Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder

    Kitzlerova E, Fisar Z, Lelkova P et al. · Medical science monitor : international medical journal of experimental and clinical research · 2018

  20. 0.86

    Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease

    Ciminelli BM, Menduti G, Benussi L et al. · Journal of Alzheimer's disease : JAD · 2020

  21. 0.85

    Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease

    Martin ER, Bronson PG, Li YJ et al. · Journal of medical genetics · 2005

  22. 0.84

    Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease

    Beyer K, Lao JI, Latorre P et al. · Annals of the New York Academy of Sciences · 2005

  23. 0.83

    Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease

    Colacicco AM, Solfrizzi V, D'Introno A et al. · Neurobiology of aging · 2009

  24. 0.83

    D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals

    Zubenko GS, Hughes HB3, Stiffler JS · Molecular psychiatry · 2001

  25. 0.83

    Apolipoprotein E region molecular signatures of Alzheimer's disease

    Kulminski AM, Huang J, Wang J et al. · Aging cell · 2018

  26. 0.82

    Isoform of APOE with retained intron 3; quantitation and identification of an associated single nucleotide polymorphism

    Dieter LS, Estus S · Molecular neurodegeneration · 2010

  27. 0.82

    Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

    Li H, Wetten S, Li L et al. · Archives of neurology · 2008

  28. 0.82

    Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease

    Poli M, Gatta LB, Lovati C et al. · Neurobiology of aging · 2008

  29. 0.81

    Exploring potential mechanisms of an African protective locus for Alzheimer's disease in APOEepsilon4 carriers

    Bertholim-Nasciben L, Nuytemans K, Van Booven D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  30. 0.81

    Specific BACE1 genotypes provide additional risk for late-onset Alzheimer disease in APOE epsilon 4 carriers

    Gold G, Blouin JL, Herrmann FR et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2003

  31. 0.79

    Results of a high-resolution genome screen of 437 Alzheimer's disease families

    Blacker D, Bertram L, Saunders AJ et al. · Human molecular genetics · 2003

  32. 0.79

    A polymorphism in the tau gene associated with risk for Alzheimer's disease

    Bullido MJ, Aldudo J, Frank A et al. · Neuroscience letters · 2000

  33. 0.78

    APOE dependent-association of PPAR-gamma genetic variants with Alzheimer's disease risk

    Combarros O, Rodriguez-Rodriguez E, Mateo I et al. · Neurobiology of aging · 2011

  34. 0.77

    The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts

    Polito L, Kehoe PG, Davin A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013

  35. 0.76

    Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort

    Guven G, Vurgun E, Bilgic B et al. · Molecular biology reports · 2019

  36. 0.76

    Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample

    Piccardi M, Congiu D, Squassina A et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2007

  37. 0.76

    Search for the elusive haplotype of the APOE polymorphism associated with Alzheimer's disease

    Cheema AN, Fan KH, Lawrence E et al. · Scientific reports · 2025

  38. 0.75

    Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk

    Reynolds CA, Hong MG, Eriksson UK et al. · Human molecular genetics · 2010

  39. 0.75

    Allele frequencies of +874T --> A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients

    Scola L, Licastro F, Chiappelli M et al. · Aging clinical and experimental research · 2003

  40. 0.74

    Alzheimer's disease risk genes and the age-at-onset phenotype

    Thambisetty M, An Y, Tanaka T · Neurobiology of aging · 2013

  41. 0.73

    Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study

    Leininger-Muller B, Hoy A, Herbeth B et al. · Neuroscience letters · 2003

  42. 0.73

    Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals

    Shang Z, Lv H, Zhang M et al. · Oncotarget · 2015

  43. 0.73

    A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution

    Zubenko GS, Hughes HB, Stiffler JS et al. · Genomics · 1998

  44. 0.72

    No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease

    Ohnuma T, Nakamura T, Takebayashi Y et al. · Dementia and geriatric cognitive disorders extra · 2012

  45. 0.71

    Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project

    Blue EE, Bis JC, Dorschner MO et al. · Dementia and geriatric cognitive disorders · 2018

  46. 0.70

    Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype

    Davidson Y, Gibbons L, Pritchard A et al. · Journal of neurology, neurosurgery, and psychiatry · 2006

  47. 0.70

    Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels

    Bekris LM, Millard SP, Galloway NM et al. · Journal of Alzheimer's disease : JAD · 2008

  48. 0.70

    Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese population

    Shibata N, Nagata T, Shinagawa S et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2013

  49. 0.69

    Genetic studies on chromosome 12 in late-onset Alzheimer disease

    Wu WS, Holmans P, Wavrant-DeVrieze F et al. · JAMA · 1998

  50. 0.68

    A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region

    Olson JM, Goddard KAB, Dudek DM · American journal of human genetics · 2002

  51. 0.67

    Association studies of transforming growth factor-beta 1 and Alzheimer's disease

    Dickson MR, Perry RT, Wiener H et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2005

  52. 0.65

    Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population

    Brown AM, Gordon D, Lee H et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2004

  53. 0.64

    Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers

    Martinez-Garcia A, Aldudo J, Recuero M et al. · Dementia and geriatric cognitive disorders · 2008

  54. 0.64

    Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE)

    Edland SD, Wavrant-De Vriese F, Compton D et al. · Neuroscience letters · 2003

  55. 0.63

    Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease

    Combarros O, Alvarez-Arcaya A, Oterino A et al. · Journal of the neurological sciences · 1999

  56. 0.62

    Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1

    Clarimon J, Bertranpetit J, Calafell F et al. · Journal of neurology · 2003

  57. 0.62

    Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE epsilon4 Non-Carriers

    Huentelman M, De Both M, Jepsen W et al. · Scientific reports · 2019

  58. 0.60

    Lack of genetic association of the UCHL1 gene with Alzheimer's disease and Parkinson's disease with dementia

    Shibata N, Motoi Y, Tomiyama H et al. · Dementia and geriatric cognitive disorders · 2012

  59. 0.60

    Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease

    Capurso C, Panza F, Seripa D et al. · Rejuvenation research · 2010

  60. 0.60

    A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease

    Romero I, Jorgensen P, Bolwig G et al. · Neuroreport · 1999

  61. 0.60

    Candidate gene analysis for Alzheimer's disease in adults with Down syndrome

    Lee JH, Lee AJ, Dang LH et al. · Neurobiology of aging · 2017

  62. 0.58

    The extended tau haplotype and the age of onset of dementia in Down syndrome

    Jones EL, Margallo-Lana M, Prasher VP et al. · Dementia and geriatric cognitive disorders · 2008

  63. 0.57

    Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD

    Gibson AM, Singleton AB, Smith G et al. · Neurology · 2000

  64. 0.56

    The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk

    Hamilton G, Harris SE, Davies G et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2012

  65. 0.56

    Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease

    Helisalmi S, Vakeva A, Hiltunen M et al. · Dementia and geriatric cognitive disorders · 2009

  66. 0.55

    Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients

    Forero DA, Arboleda G, Yunis JJ et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2006

  67. 0.55

    Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism

    Fullerton SM, Clark AG, Weiss KM et al. · American journal of human genetics · 2000

  68. 0.55

    Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: the VITA and Milano studies

    Grunblatt E, Reif A, Jungwirth S et al. · Journal of psychiatric research · 2011

  69. 0.54

    Association study of cholesterol-related genes in Alzheimer's disease

    Wollmer MA, Sleegers K, Ingelsson M et al. · Neurogenetics · 2007

  70. 0.54

    MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEvarepsilon4 Noncarriers: Results from the Dementia Genetics Spanish Consortium

    Pastor P, Moreno F, Clarimon J et al. · Journal of Alzheimer's disease : JAD · 2016

  71. 0.53

    Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland

    Hiltunen M, Mannermaa A, Thompson D et al. · Neurology · 2001

  72. 0.53

    Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms

    Orlacchio A, Kawarai T, Polidoro M et al. · Neuroscience letters · 2002

  73. 0.52

    An Ig gamma Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E epsilon4 Genotype

    Pandey JP, Olsson J, Weidung B et al. · Journal of immunology (Baltimore, Md. : 1950) · 2020

  74. 0.52

    Alzheimers disease is not associated with the hypertension genetic risk factors PLA(2) or G protein beta3, either independently or interactively with apolipoprotein E

    Town T, Paris D, Parker TA et al. · American journal of medical genetics · 1999

  75. 0.52

    Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease

    De Ferrari GV, Papassotiropoulos A, Biechele T et al. · Proceedings of the National Academy of Sciences of the United States of America · 2007

  76. 0.50

    Presenilin E318G variant and Alzheimer's disease risk: the Cache County study

    Hippen AA, Ebbert MTW, Norton MC et al. · BMC genomics · 2016

  77. 0.50

    Association between H2 haplotype of microtubule associated protein tau gene (deletion / insertion) with Alzheimer Disease in Tunisian patients

    Fray S, Achouri-Rassas AA, Hadj Fredj S et al. · Neurological research · 2022

  78. 0.50

    Effect of heterogeneity on the chromosome 10 risk in late-onset Alzheimer disease

    Liang X, Martin ER, Schnetz-Boutaud N et al. · Human mutation · 2007

07load · late-onset70편

  1. 0.94

    Association study of susceptibility genes for late-onset Alzheimer's disease in the Japanese population

    Ohara T, Ninomiya T, Hirakawa Y et al. · Psychiatric genetics · 2012

  2. 0.94

    ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease

    Medway CW, Abdul-Hay S, Mims T et al. · Molecular neurodegeneration · 2014

  3. 0.92

    Association and Gene-Gene Interactions Study of Late-Onset Alzheimer's Disease in the Russian Population

    Bocharova A, Vagaitseva K, Marusin A et al. · Genes · 2021

  4. 0.92

    Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese

    Takei N, Miyashita A, Tsukie T et al. · Genomics · 2009

  5. 0.92

    Association Analysis of Polymorphisms in TOMM40, CR1, PVRL2, SORL1, PICALM, and 14q32.13 Regions in Colombian Alzheimer Disease Patients

    Ortega-Rojas J, Morales L, Guerrero E et al. · Alzheimer disease and associated disorders · 2016

  6. 0.92

    Relationship between apolipoprotein E, D10S1225 polymorphisms and late-onset Alzheimer's disease

    Zhang Ts, Wang Hq, Wang Wy et al. · Chinese medical journal · 2006

  7. 0.91

    Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes

    Gharesouran J, Rezazadeh M, Khorrami A et al. · Journal of molecular neuroscience : MN · 2014

  8. 0.89

    Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association

    Yu CE, Seltman H, Peskind ER et al. · Genomics · 2007

  9. 0.88

    Genetic association study between rs2234253 (p.T96K) variant of TREM2 and Alzheimer's disease in a Tunisian population

    Achouri-Rassas A, Fray S, Said Z et al. · Neurological research · 2025

  10. 0.88

    Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype

    Izzo G, Forlenza OV, Santos Bd et al. · Clinics (Sao Paulo, Brazil) · 2013

  11. 0.88

    Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?

    Lambert JC, Mann D, Richard F et al. · Journal of neurology, neurosurgery, and psychiatry · 2005

  12. 0.87

    Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese

    Wang B, Zhang C, Zheng W et al. · Neuroscience letters · 2004

  13. 0.87

    Neither the tumor necrosis factor alpha-308 A/G polymorphism nor the alpha2-macroglobulin polymorphism was associated with late-onset Alzheimer's disease in the Chinese population

    Zhang P, Yang Z, Wan CL et al. · Yi chuan xue bao = Acta genetica Sinica · 2004

  14. 0.86

    The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes

    Linnertz C, Anderson L, Gottschalk W et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

  15. 0.86

    Whole-genome sequencing reveals an East Asian-specific rare variant of INPP5J associated with Alzheimer's disease

    Kimura T, Yamakawa A, Mitsumori R et al. · Translational psychiatry · 2026

  16. 0.85

    APOE Variants in an Iberian Alzheimer Cohort Detected through an Optimized Sanger Sequencing Protocol

    Gonzalez RD, Gomes I, Gomes C et al. · Genes · 2020

  17. 0.85

    Familial late-onset Alzheimer's disease: description of an Italian family with four affected siblings and one case of early-onset dementia in the preceding generation

    Abbate C, Arosio B, Cantatore A et al. · Aging clinical and experimental research · 2016

  18. 0.85

    Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients

    Gaj P, Paziewska A, Bik W et al. · Journal of Alzheimer's disease : JAD · 2012

  19. 0.84

    Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility

    Rezazadeh M, Khorrami A, Yeghaneh T et al. · Neuromolecular medicine · 2016

  20. 0.84

    Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease

    Cruchaga C, Nowotny P, Kauwe JSK et al. · Archives of neurology · 2011

  21. 0.84

    GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

    Reiman EM, Webster JA, Myers AJ et al. · Neuron · 2007

  22. 0.83

    Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci

    Dato S, De Rango F, Crocco P et al. · Aging cell · 2023

  23. 0.82

    The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort

    Alaylioglu M, Gezen-Ak D, Dursun E et al. · Journal of geriatric psychiatry and neurology · 2016

  24. 0.82

    Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients

    Nishimura AL, Oliveira JRM, Mitne-Neto M et al. · Journal of molecular neuroscience : MN · 2004

  25. 0.82

    The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-varepsilon4 Carriers

    Montesanto A, Crocco P, Anfossi M et al. · Journal of Alzheimer's disease : JAD · 2016

  26. 0.82

    Association of CD33 rs3865444:C>A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE epsilon4 allele

    Javor J, Durmanova V, Parnicka Z et al. · International journal of immunogenetics · 2020

  27. 0.81

    The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease

    Wang B, Jin F, Yang Z et al. · Journal of molecular neuroscience : MN · 2006

  28. 0.80

    A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease

    Roses AD, Lutz MW, Amrine-Madsen H et al. · The pharmacogenomics journal · 2010

  29. 0.80

    Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities

    Naj AC, Beecham GW, Martin ER et al. · PLoS genetics · 2010

  30. 0.79

    TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity

    Maruszak A, Peplonska B, Safranow K et al. · Journal of Alzheimer's disease : JAD · 2012

  31. 0.79

    Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE

    Wijsman EM, Pankratz ND, Choi Y et al. · PLoS genetics · 2011

  32. 0.79

    TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease

    Chu SH, Roeder K, Ferrell RE et al. · Neurobiology of aging · 2011

  33. 0.77

    GAB2 is not associated with late-onset Alzheimer's disease in Japanese

    Miyashita A, Arai H, Asada T et al. · European journal of human genetics : EJHG · 2009

  34. 0.77

    The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patients

    Helisalmi S, Hall A, Merilainen EH et al. · Neuro-degenerative diseases · 2014

  35. 0.77

    SORL1 Polymorphisms in Mexican Patients with Alzheimer's Disease

    Toral-Rios D, Ruiz-Sanchez E, Rodriguez NLM et al. · Genes · 2022

  36. 0.77

    Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele

    Bernardini S, Bellincampi L, Ballerini S et al. · Clinical chemistry · 2005

  37. 0.75

    Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci

    Lee JH, Cheng R, Graff-Radford N et al. · Archives of neurology · 2008

  38. 0.74

    Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease

    Tilley L, Morgan K, Grainger J et al. · European journal of human genetics : EJHG · 1999

  39. 0.74

    Replication study of genome-wide associated SNPs with late-onset Alzheimer's disease

    Burns LC, Minster RL, Demirci FY et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2011

  40. 0.72

    Integrative genomics identifies APOE epsilon4 effectors in Alzheimer's disease

    Rhinn H, Fujita R, Qiang L et al. · Nature · 2013

  41. 0.70

    Association studies of 22 candidate SNPs with late-onset Alzheimer's disease

    Figgins JA, Minster RL, Demirci FY et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2009

  42. 0.70

    The association of mitochondrial aldehyde dehydrogenase gene (ALDH2) polymorphism with susceptibility to late-onset Alzheimer's disease in Chinese

    Wang B, Wang J, Zhou S et al. · Journal of the neurological sciences · 2008

  43. 0.70

    Genome-wide scan of copy number variation in late-onset Alzheimer's disease

    Heinzen EL, Need AC, Hayden KM et al. · Journal of Alzheimer's disease : JAD · 2010

  44. 0.69

    Polygenic risk scores in familial Alzheimer disease

    Tosto G, Bird TD, Tsuang D et al. · Neurology · 2017

  45. 0.69

    No association between a presenilin 1 polymorphism and Alzheimer disease

    Romas SN, Mayeux R, Tang MX et al. · Archives of neurology · 2000

  46. 0.68

    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease

    Fardo DW, Gibbons LE, Mukherjee S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017

  47. 0.68

    Genetic association of BACE1 gene polymorphism C786G with late-onset Alzheimer's disease in Chinese

    Kan R, Wang B, Zhang C et al. · Journal of molecular neuroscience : MN · 2005

  48. 0.65

    Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer's disease

    Grace C, Clarke R, Goel A et al. · Scientific reports · 2018

  49. 0.65

    The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk

    Maruszak A, Safranow K, Branicki W et al. · Journal of Alzheimer's disease : JAD · 2011

  50. 0.65

    Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk

    Hohman TJ, Cooke-Bailey JN, Reitz C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016

  51. 0.64

    Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis

    Webster J, Reiman EM, Zismann VL et al. · International journal of molecular epidemiology and genetics · 2010

  52. 0.62

    A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease

    Crawford FC, Freeman MJ, Schinka JA et al. · Neurology · 2000

  53. 0.61

    TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients

    Bagnoli S, Piaceri I, Tedde A et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2013

  54. 0.61

    Investigation of base excision repair gene variants in late-onset Alzheimer's disease

    Ertuzun T, Semerci A, Cakir ME et al. · PloS one · 2019

  55. 0.61

    Sequence variants of toll like receptor 4 and late-onset Alzheimer's disease

    Chen YC, Yip PK, Huang YL et al. · PloS one · 2012

  56. 0.61

    Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-epsilon4 carriers

    Aidaralieva NJ, Kamino K, Kimura R et al. · Journal of human genetics · 2008

  57. 0.61

    Lymphocyte-specific protein tyrosine kinase is a novel risk gene for Alzheimer disease

    Zhong W, Yamagata HD, Taguchi K et al. · Journal of the neurological sciences · 2005

  58. 0.59

    An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk

    Rao S, Ghani M, Guo Z et al. · Neurobiology of aging · 2018

  59. 0.57

    Effects of SORL1 gene on Alzheimer's disease. Focus on gender, neuropsychiatric symptoms and pro-inflammatory cytokines

    Olgiati P, Politis A, Albani D et al. · Current Alzheimer research · 2013

  60. 0.57

    Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease

    Rosenthal SL, Wang X, Demirci FY et al. · American journal of neurodegenerative disease · 2012

  61. 0.57

    Association analysis of dynamin-binding protein (DNMBP) on chromosome 10q with late onset Alzheimer's disease in a large caucasian UK sample

    Morgan AR, Hollingworth P, Abraham R et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2009

  62. 0.55

    Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease

    Tedde A, Bagnoli S, Piaceri I et al. · Neuroscience letters · 2010

  63. 0.54

    Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEepsilon4 carriers

    Liang WS, Chen K, Lee W et al. · NeuroImage · 2011

  64. 0.54

    Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease?

    Nishimura AL, Guindalini C, Oliveira JRM et al. · Journal of molecular neuroscience : MN · 2005

  65. 0.53

    Assessing the association between common functional Nuclear Factor Kappa-b gene polymorphisms (NFKB1, NFKBIZ, NFKBIA) and Alzheimer s disease

    Vazquez-Coto D, Perez-Oliveira S, Menendez-Gonzalez M et al. · Behavioural brain research · 2025

  66. 0.53

    Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease

    Wang B, Zhou S, Yang Z et al. · Journal of the neurological sciences · 2008

  67. 0.52

    Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease

    Fidani L, Goulas A, Mirtsou V et al. · Neuroscience letters · 2002

  68. 0.51

    A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 alpha4 Subunit with Increased Risk of Alzheimer's Disease

    Durmanova V, Parnicka Z, Javor J et al. · Mediators of inflammation · 2018

  69. 0.51

    Shared genetic etiology underlying Alzheimer's disease and major depressive disorder

    Lutz MW, Sprague D, Barrera J et al. · Translational psychiatry · 2020

  70. 0.50

    Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China

    Jiao B, Liu X, Zhou L et al. · PloS one · 2015

08chinese · han42편

  1. 0.96

    Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population

    Wu P, Li HL, Liu ZJ et al. · Clinical interventions in aging · 2015

  2. 0.95

    Association of Gene Polymorphisms in APOE and BIN1 With Dementia of Alzheimer's Type Susceptibility in Chinese Han Population

    Li X, Zhang Y, Chen X et al. · Frontiers in psychiatry · 2021

  3. 0.94

    TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population

    Zhu Z, Yang Y, Xiao Z et al. · Aging clinical and experimental research · 2021

  4. 0.91

    Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population

    Wang S, Guan L, Luo D et al. · The journal of nutrition, health & aging · 2017

  5. 0.90

    TMEM106B and APOE polymorphisms interact to confer risk for late-onset Alzheimer's disease in Han Chinese

    Lu RC, Wang H, Tan MS et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2014

  6. 0.83

    SORCS1 and APOE polymorphisms interact to confer risk for late-onset Alzheimer's disease in a Northern Han Chinese population

    Wang HF, Yu JT, Zhang W et al. · Brain research · 2012

  7. 0.82

    Association between the COMTVal158Met Genotype and Alzheimer's Disease in the Han Chinese Population

    Ji Y, Shi Z, Liu M et al. · Dementia and geriatric cognitive disorders extra · 2014

  8. 0.82

    Genetic studies of A2M and BACE1 genes in Chinese Han Alzheimer's disease patients

    Cai L, Tang G, Chen L et al. · Neuroreport · 2005

  9. 0.79

    Genetic Association of FERMT2, HLA-DRB1, CD2AP, and PTK2B Polymorphisms With Alzheimer's Disease Risk in the Southern Chinese Population

    Yan Y, Zhao A, Qui Y et al. · Frontiers in aging neuroscience · 2020

  10. 0.79

    Evaluation of mild cognitive impairment genetic susceptibility risks in a Chinese population

    Zhang Y, Li X, Hu Y et al. · BMC psychiatry · 2022

  11. 0.78

    Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population

    Xiao Q, Liu ZJ, Tao S et al. · Oncotarget · 2015

  12. 0.77

    Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese

    Zhang P, Yang Z, Zhang C et al. · Neuroscience letters · 2003

  13. 0.77

    Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer's disease patients carrying the APOE epsilon4 Allele

    Yin J, Feng W, Yuan H et al. · Neuropsychiatric disease and treatment · 2019

  14. 0.77

    Association between CYP17A1 rs3824755 and rs743572 gene polymorphisms and Alzheimer's disease in the Chinese Han population

    Xie L, Yan H, Shi L et al. · Neuroscience letters · 2016

  15. 0.77

    Validate association of gene loci and establish genetic risk prediction models for late-onset Alzheimer's disease in Chinese populations

    Li F, Zheng M, Jia J · Journal of Alzheimer's disease : JAD · 2025

  16. 0.77

    SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan

    Chou CT, Liao YC, Lee WJ et al. · Alzheimer's research & therapy · 2016

  17. 0.70

    Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility

    Yu JT, Tan L, Ou JR et al. · Brain research · 2008

  18. 0.69

    The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population

    Sun Y, Shi J, Zhang S et al. · Neuroscience letters · 2005

  19. 0.69

    Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population

    Ma JF, Liu Lh, Zhang Y et al. · American journal of Alzheimer's disease and other dementias · 2011

  20. 0.68

    Association of polymorphisms in the LRP1 and A2M genes with Alzheimer's disease in the northern Chinese Han population

    Yuan Q, Wang F, Xue S et al. · Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2013

  21. 0.67

    Association study of TREM2 polymorphism rs75932628 with late-onset Alzheimer's disease in Chinese Han population

    Ma J, Zhou Y, Xu J et al. · Neurological research · 2014

  22. 0.66

    Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease

    Yu JT, Tan L, Song JH et al. · Brain research · 2009

  23. 0.66

    Relationship Between FERMT2, CELF1, COPI, CHRNA2, and ABCA7 Genetic Polymorphisms and Alzheimer's Disease Risk in the Southern Chinese Population

    Ding Y, Chen H, Yan Y et al. · Journal of Alzheimer's disease reports · 2023

  24. 0.66

    Association between promoter polymorphisms in anterior pharynx-defective-1a and sporadic Alzheimer's disease in the North Chinese Han population

    Wang Y, Jia J · Neuroscience letters · 2009

  25. 0.65

    Association of alpha 2-macroglobulin polymorphisms and Alzheimer disease in Mainland Han Chinese

    Chen D, Zhang JW, Zhang ZX et al. · Journal of the neurological sciences · 2004

  26. 0.62

    An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease

    Liu QY, Yu JT, Miao D et al. · Neurobiology of aging · 2013

  27. 0.62

    Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population

    Xue S, Jia L, Jia J · Neuroscience letters · 2009

  28. 0.61

    Genetic association between polymorphisms of Pen2 gene and late onset Alzheimer's disease in the North Chinese population

    Jia L, Ye J, L V H et al. · Brain research · 2007

  29. 0.60

    Association of polymorphism of DNA repair gene XRCC1 with sporadic late-onset Alzheimer's disease and age of onset in elderly Han Chinese

    Qian Y, Chen W, Wu J et al. · Journal of the neurological sciences · 2010

  30. 0.59

    Lack of association between PICALM rs3851179 polymorphism and Alzheimer's disease in Chinese population and APOEepsilon4-negative subgroup

    Liu G, Zhang L, Feng R et al. · Neurobiology of aging · 2013

  31. 0.59

    No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Chinese

    Wang YC, Liu TY, Liu HC et al. · Neuropsychobiology · 1999

  32. 0.57

    Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese

    Chen DW, Yang JF, Tang Z et al. · Brain research · 2008

  33. 0.56

    GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han

    Lin K, Tang M, Han H et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2010

  34. 0.56

    The association of the regulatory region of the presenilin-2 gene with Alzheimer's disease in the Northern Han Chinese population

    Liu Z, Jia J · Journal of the neurological sciences · 2008

  35. 0.56

    Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients

    Li Y, Chu LW, Chen YQ et al. · Dementia and geriatric cognitive disorders · 2006

  36. 0.56

    Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population

    Tan L, Yu JT, Zhang W et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013

  37. 0.54

    Lack of association between the polymorphisms of beta-site APP-cleaving enzyme 2 (BACE2) 5'-flanking region and sporadic Alzheimer's disease

    Yu Y, Jia J · Brain research · 2009

  38. 0.53

    Lack of association between rs597668 polymorphism near EXOC3L2 and late-onset Alzheimer's disease in Han Chinese

    Liu QY, Miao D, Yu JT et al. · Neuroscience letters · 2012

  39. 0.51

    Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer's Disease in Han Chinese

    Chi S, Song JH, Tan MS et al. · Molecular neurobiology · 2016

  40. 0.51

    A variant within FGF1 is associated with Alzheimer's disease in the Han Chinese population

    Tao QQ, Sun YM, Liu ZJ et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2014

  41. 0.51

    Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer's disease in Han Chinese

    Wang YL, Tan MS, Yu JT et al. · Journal of neuroinflammation · 2013

  42. 0.50

    Single nucleotide polymorphism rs7294919 on chromosome 12q24.22 is associated with late-onset Alzheimer's disease in Han Chinese

    Ma LL, Ou JR, Zhang W et al. · Neuroscience letters · 2014